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ABSTRACT 
  
Stroke remains the leading cause of adult disability in developed countries. Most 
survivors live with residual motor impairments that severely diminish independence and 
quality of life. After stroke, the only accepted treatment for these patients is motor 
rehabilitation. However, the amount and kind of rehabilitation required to induce 
clinically significant improvements in motor function is rarely given due to the 
constraints of our current health care system. Research reported in this dissertation 
contributes towards developing adjuvant therapies that may augment the impact of motor 
rehabilitation and improve functional outcome. These studies have demonstrated 
reorganization of maps within motor cortex as a function of experience in both healthy 
and brain-injured animals by using intracortical microstimulation technique. Furthermore, 
synaptic plasticity has been identified as a key neural mechanism in directing motor map 
plasticity, evidenced by restoration of movement representations within the spared 
cortical tissue accompanied by increase in synapse number translating into motor 
improvement after stroke. There is increasing evidence that brain-derived neurotrophic 
factor (BDNF) modulates synaptic and morphological plasticity in the developing and 
mature nervous system. Unfortunately, BDNF itself is a poor candidate because of its 
short half-life, low penetration through the blood brain barrier, and activating multiple 
receptor units, p75 and TrkB on the neuronal membrane. In order to circumvent this 
problem efficacy of two recently developed novel TrkB agonists, LM22A-4 and 7,8-
dihydroxyflavone, that actively penetrate the blood brain barrier and enhance functional 
recovery. Findings from these dissertation studies indicate that administration of these 
ii 
pharmacological compounds, accompanied by motor rehabilitation provide a powerful 
therapeutic tool for stroke recovery. 
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Chapter 1 
INTRODUCTION 
1.1 Overview 
Every year approximately, 750,000 Americans suffer a stroke. Of the 80% who 
survive, most will experience upper extremity impairments, making stroke the leading 
cause of adult disability in the United States (AHA, update 2011). The only clinically 
proven treatment for motor impairment is motor rehabilitation. Unfortunately, patient 
response is highly variable reflecting both the heterogeneity of the disorder and our lack 
of understanding of the neurobiological substrates of functional improvement. Animal 
models of stroke have become a critical part of neurorehabilitation as they serve to guide 
the development of more effective rehabilitation therapies. Over the last decade there has 
been a concerted effort by researchers to develop better animal models that include more 
comprehensive measures of both motor impairment and subsequent improvement in 
response to rehabilitation. Second, animal research has expanded beyond studies of 
neuroprotection to studies directed at identifying the fundamental neural substrates that 
support rehabilitation-dependent functional improvement.  Further, these studies have 
begun to reveal the key neural signaling systems that drive compensatory and restorative 
neural plasticity within residual brain areas that supports functional improvement. The 
general hypothesis guiding the studies within this dissertation research is that by 
combining motor rehabilitation with adjuvant, plasticity promoting interventions that 
drive neural plasticity can significantly enhance motor function after stroke.  
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1.2 Cerebral pathophysiology  
 A blockade in oxygen supply for a few minutes is sufficient to do irrepairable 
damage to the human brain often resulting in stroke. Essentially stroke refers to an 
umbrella of conditions caused by the occlusion or hemorrhage of blood vessels supplying 
the brain. Most often, blood flow is compromised within the territory of an occluded 
blood vessel, referred to as ischemia. 80% of human strokes are ischemic in origin (Roger 
VL, Heart disease and stroke statistics-2012 update). In all instances, stroke ultimately 
involves death and dysfunction of brain cells and neurological deficits that reflect the 
location and size of the compromised brain area.  
 Ischemic stroke is characterized by complex spatial and temporal events developing 
progressively over hours to days. In most clinical settings, the first phase is generally 
referred to as the sub-acute phase (0-1 week), followed by 90 days of acute phase and 
from 6 month onwards the patient is classified to be in chronic phase (Cramer & Riley, 
2008). During the acute and sub-acute phases there is a cascade of neurodestructive 
events that occur in the brain tissue.  
 Brain tissue affected by a stroke can be divided into a core region where blood flow 
has dropped substantially resulting in necrosis of the tissue, and a surrounding penumbral 
region where blood flow is also reduced. Within center or core of an ischemic territory, 
blood flow deficits accompanied by low ATP levels and energy stores, ionic disruptions 
and metabolic failures are severe leading to major cell death (Ames, 1992). At least three 
fundamental molecular mechanisms have been identified that are inextricably linked and 
contribute to ischemic cell death. Excitotoxicity and ionic imbalance, 
oxidative/nitrosative stress and apoptotic-like cell death. These mechanisms mediate 
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injury primarily within neurons, glia and vascular elements. They also pose a serious risk 
to cell bodies, their processes and synaptic endings (Nedergaard, Gjedde, & Diemer, 
1986).  
 The reactive oxygen radical is a key mediator of tissue damage after reperfusion of 
the brain. Mitochondria are strongly implicated, and this might be due to excessive 
superoxide production during electron transport and inhibition of mitochondrial electron 
transport mechanisms by free radicals, leading to even more oxygen radical generation 
(Fiskum, Murphy, & Beal, 1999)(Chan et al, 2001). Free radicals are also generated 
during the inflammatory response after ischemia. Not surprisingly, then, oxidative stress, 
excitotoxicity, energy failure and ionic imbalances are intricately linked, and contribute 
to ischemic cell death.  
 The end result of the cellular changes is widespread neurophysiological changes 
that result in significant functional impairments. However, the impairments are not the 
manifestation for the lost tissue but rather the ability of the residual tissue to maintain 
function. The capacity to maintain function is related to the restoration, recruitment and 
retraining of residual tissue that is mediated by neural plasticity. 
 
1.3 Functional Impairments 
Following unilateral stroke there is significant loss of function in the body side 
contralateral to the damage and a robust degenerative-regenerative cascade of events in 
both hemispheres. The most common and widely recognized impairment caused by 
stroke is motor impairment, which can be regarded as a loss or limitation of function in 
muscle control or movement or a limitation in mobility (Wade, Collen, Robb, & Warlow, 
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1992). Motor impairment after stroke typically affects the control of movement of the 
face, arm, and leg of one side of the body (Warlow, Sudlow, Dennis, Wardlaw, & 
Sandercock, 2003) and affects about 80% of patients. Only 5% of adult stroke survivors 
regain full function of the upper limb and 20% regain no functional use. Upper limb 
dysfunction remains an important hurdle for many stroke survivors. Frequently this loss 
is compensated for by overuse of the less-affected body side to accomplish everyday 
living tasks (e.g. brushing teeth, drinking coffee). This behavior is accompanied by a 
“learned disuse” (Wolf et al., 2006) of the impaired side thought to occur due to repeated 
experience with its ineptness.  
Therefore, much of the focus of stroke rehabilitation, and in particular the work of 
physiotherapists and occupational therapists, is on the recovery of impaired movement 
and the associated functions. 
1.3.1 Rehabilitation following stroke 
 After unilateral brain damage, some functional improvements in the impaired 
limb have been found following practice on a skilled reaching task (e.g. Whishaw, 2000; 
Gharbawie & Whishaw, 2005; Allred, Maldonado, Hsu, & Jones, 2005; Nudo et al., 
1996). Exercise following unilateral lesions did not result in improvement in impaired 
forelimb skill (Maldonado et al., 2005), which suggests that improvements result from 
practice on a motor skill task, not simply from activity. As previously noted, in intact 
rats, experience with a skilled reaching task (reaching and grasping for food) results in an 
increase in pyramidal neuron dendritic arborization (Greenough et al., 1985; Withers and 
Greenough, 1989) as well as in changes in motor map representations, including an 
increase in distal forelimb (i.e. digit and wrist) representations and a decrease in proximal 
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forelimb (elbow/shoulder) representations (e.g. Remple, Bruneau, VandenBerg, 
Goertzen, & Kleim, 2001; Kleim et al., 1998). Following motor cortex damage, 
depending on lesion size and location, training with the impaired limb has been found to 
induce motor map representational changes in monkeys (Friel & Nudo, 1998; reviewed in 
Nudo, 2003), rats (Castro-Alamancos & Borrell, 1995) and humans (Liepert et al., 2000; 
Weiller, Ramsay, Friston, & Frackowiak, 1993; Cramer, Moore, Finklestein, & Rosen, 
2000; Green, 2003). 
Motor rehabilitation restores skilled movement, reinstates motor maps (Nudo 1996; 
Frost 2003; Kleim 2003) and increases synapse number. Similar effects can be seen 
following acute pharmacological manipulations. Transient inhibition of protein synthesis 
within motor cortex causes an enduring reduction in motor map area and skilled 
movement impairments. Within cortical areas lacking movement representations, there is 
also a loss of synapses but not neurons, indicating again the disruption in cortical 
circuitry. However, both the motor maps and skilled movement can be restored with 
motor training 
 
1.4 Need for effective rehabilitation and adjuvant therapies 
Currently there are no universally accepted, standardized therapies established in the 
clinic. The therapies employed more often reflect the personal experience of the 
therapists than evidence-based practice. The present therapies employed rarely engage all 
of the key behavioral signals known to drive plasticity. Neurorehabilitation is considered 
as a multidisciplinary and multimodal concept to help neurological patients improve 
physiological functioning, activity, and participation by creating learning situations, 
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inducing several means of recovery. The central nervous system of adult human beings 
has an astounding potential for recovery and adaptability, which can be selectively 
promoted. Use of drugs targeting specific neural signaling systems have been shown to 
enhance functional outcome in both animal studies and early clinical trials. However, the 
approach has some limitations. First, the cell signaling systems that drive plasticity are 
very complex and may change as the CNS adapts over time to the injury. So activating 
one cell signaling system alone may not be sufficient to drive all of the different cellular 
systems required to induce experience-dependent plasticity over time. Despite these 
limitations, pharmacology will undoubtedly play a role in neurorehabilitation. Regardless 
of what adjuvant therapies are discovered, they will only be effective if they are paired 
with the best behavioral therapies. Hence, the challenge for the researchers is to design an 
intervention that maximizes specific signals for an individual patient. For this purpose the 
role of animal models in development of novel therapies has been instrumental. 
 
1.5 Advantages of using rat models 
Modeling human neurological conditions in animals is not an easy task, primarily 
because the same neurological disorder may have different physical manifestations 
across different species. The key to successfully modeling human neurological 
symptoms, such as those associated with stroke, is to first identify functional rather than 
physical similarities in neurological impairments. No laboratory animal has been studied 
in more detail than the rat and this work has revealed a number of motor behaviors that 
can be used to study both motor impairment and recovery associated with various 
neurological disorders (Cenci, Whishaw, & Schallert, 2002). In addition to species-
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specific motor behaviors, detailed analysis of limb movement shows very similar motor 
components in human upper extremity and rat forelimb movement during reaching 
behavior (Whishaw et al. 2002). This information has led to the development of a 
battery of sensorimotor tests that can measure various aspects of both motor impairment 
and recovery after ischemic insult. Further, investigators' extensive knowledge of the 
anatomical and neurophysiological organization of the rodent motor system facilitates 
the identification of the neural mechanisms underlying motor recovery, information that 
in turn allows for the development of novel adjuvant therapies that may enhance 
recovery or limit impairment. In addition, rat models enable the use of more complex 
experimental designs to examine issues such as time course of recovery and dose-
response relationships that may not feasible in other animal models.  
1.5.1 Rats are good a animal model 
 Frequently following stroke, humans lose the ability to accurately shape their paretic 
hand for grasping objects and show deficits in fine skilled movements (Lang, DeJong, & 
Beebe, 2009). Some deficits following stroke can be modeled in rats, which have very 
skillful use of the forepaw. Rats present a good repertoire of upper extremity motor 
movements that mimic human stroke like symptoms. There are established sensorimotor 
tests that measure deficits incurred from brain damage (Kleim, Boychuk, & Adkins, 
2007; Cenci, Whishaw, & Schallert, 2002), including single pellet retrieval task (a reach 
to grasp task). Recovery of function can be linked with resultant changes in neural 
activity and connectivity. A recent review from Cramer (2008) details findings that 
suggest that there are similarities in the ways rats and humans recover after stroke. For 
example, reorganization in the peri-infarct zone in rats and humans is a major contributor 
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to recovery of motor function in both species. Although it is not possible to duplicate all 
components of human stroke condition in an animal model, but with the development of 
various models, researchers have been successful in identifying pathways that are 
involved in pathophysiology of stroke, and characterize plasticity-promoting mechanisms 
for functional recovery. 
 
1.6 Anatomy of the rat sensorimotor cortex 
1.6.1 General organization. The forelimb area of the rat sensorimotor cortex (SMC) is 
partially overlapped between primary motor (M1) and primary sensory (S1) cortices 
(Donoghue & Wise, 1982). S1, which is posterior and lateral to M1, receives sensory 
input primarily in layer IV, the granular region, and is characterized by receptive fields 
that respond to sensory stimuli. M1, which lacks a clearly defined granular layer, 
contains large pyramidal neurons in layer V and is defined based on populations of 
neurons that, when stimulated, elicit distinct body movements (Sanderson, Welker, & 
Shambes, 1984; Wise & Jones, 1977) (Donoghue & Wise, 1982). This is the basis of the 
motor maps revealed using ICMS (Intracortical Microstimulation) procedures. Layer V 
pyramidal neurons within the overlap zone synapse on spinal motor neurons to elicit 
forelimb movements (Hicks & D'Amato, 1977; Valverde, 1966).  The caudal and rostral 
forelimb areas are distinct from each other and are distinguishable based on 
characteristics of their movement representations. The SMC lesions used in these 
dissertation studies are aimed at the caudal forelimb area. The caudal forelimb 
representation area, and not the rostral area, may be the more important contributor to 
skilled motor learning (e.g., Gharbawie, Karl, & Whishaw, 2007). It receives input from 
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S1 (Sievert & Neafsey, 1986) and is the targeted region for the lesions induced in these 
dissertation studies. Damage to this region in rats has been shown to result in 
pronounced deficits in the forelimb contralateral to the lesion (Allred & Jones, 2004; 
Hsu & Jones, 2005; Maldonado et al., 2005). 
 
1.6.2 Ascending and descending projections. S1 receives thalamic input from the 
ventral posterior nucleus (Donaldson, Hand, & Morrison, 1975; Wise & Jones, 1978) and 
the posterior thalamic complex, which terminates mainly in layer IV and lower layer III 
(Koralek, Jensen, & Killackey, 1988; Killackey, 1973; Killackey & Sherman, 2003). M1 
also receives input from the ventral posterior thalamus, which mainly terminates in layer 
III (Killackey, 1973; Killackey & Sherman, 2003). The overlapping region of M1/S1 
receives extensive input from the ventrolateral thalamus with projections terminating in 
layers II/III and V (Donoghue & Parham, 1983). The ventrolateral thalamus receives 
input from several regions, including the spinal cord, cerebellum, and basal ganglia 
(Donoghue & Parham, 1983). Projections originating in S1 terminate in areas involved in 
motor behavior, including the striatum and pontine nuclei (Wise & Jones, 1977; 
Donoghue & Parham, 1983; Mihailoff, Lee, Watt, & Yates, 1985). Layer V neurons 
originating in M1 then project to the spinal cord (Leong, 1983; Bates & Killackey, 1984; 
Miller, 1987) red nucleus, and pons (Legg et al.,1989; Mihailoff et al., 1985)), bilaterally 
to striatum (Donogue & Kitai, 1981), and also to the reticular formation (Valverde, 
1966). 
The corticospinal tract is mostly a crossed pathway, but approximately 5-10% of 
this pathway is estimated to be ipsilateral (Brosamle & Schwab). Layer V motor neurons 
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project to the spinal cord via corticospinal projections. Damage to the corticospinal tract 
(CST) can result in deficits in motor tasks, though the medial and lateral portions of the 
CST appear to contribute to different aspects of motor performance. The SMC 
contributes to both pathways. Rats with lateral CST lesions (aimed at C5 of the spinal 
cord) have more enduring deficits on a skilled reaching task compared to medial CST 
lesion animals, though the medial CST appears to play a larger role in mediating grip 
strength (Anderson, Gunawan, & Steward, 2007).  
1.6.3 Role of ipsilesional corticospinal tract. Most of the motor cortex contribution to 
the corticospinal tract (CST) is crossed in the rat, such that the contralateral cortex is 
responsible for moving the limb. However, there is some ipsilateral contribution (about 5-
10%, Brosamle & Schwab, 1997). A question is whether the 10% of this pathway arising 
from the contralesional cortex mediates recovery of the impaired forelimb. If so, learning 
with the intact forelimb may also interfere with motor relearning of the skilled task with 
the impaired forelimb because it interferes with the takeover of the impaired limb by the 
ipsilateral CST. The likelihood of this effect, however, seems low. In animals with 
transections of the corpus callosum the maladaptive effect of intact forelimb training on 
impaired recovery was absent. If this pathway was involved in mediating recovery of the 
impaired forelimb, the maladaptive effect should have still been present in transected 
animals. Additionally, after lesion animals had recovered on a skilled reaching task, a 
second lesion in the contralateral (intact) hemisphere did not reinstate impaired forelimb 
deficits greater than deficits seen in animals with a unilateral lesion, suggesting that it is 
not normally responsible for its recovery, at least after these focal SMC lesions 
(Maldonado, Allred, Hsu, & Jones, 2006). The contribution of the ipsilateral, uncrossed 
11 
pathway has previously been shown not to contribute noticeably to skilled reaching 
behavior and the uncrossed pathway also does not contribute to motor recovery when the 
crossed pathway is severed (Whishaw & Metz, 2002). However, the ipsilateral 
components of the CST may at least sometimes play a larger role in mediating recovery 
following some types of brain damage, perhaps particularly after very large lesions, when 
there is little of the peri-lesion cortex remaining. 
 
1.7 Motor Maps As A Neural Substrate for Motor Behavior 
1.7.1 Motor Maps Illustrating the Somatotopic Organization of M1. In the history 
of work on motor function of the CNS, a variety of techniques have been used to identify 
brain structures projecting to motoneurons. Fritsch and Hitzig (1870) first evoked muscle 
contractions by applying electrical stimulation to the motor area of the cerebral cortex in 
the dog (Fetz, 1991). The motor map is assessed using microstimulation, whereby a 
microelectrode is used to excite a small population of cortical neurons. The motor 
responses evoked by microstimulation reflect a complex combination of activation of 
intracortical (Jankowska and others 1975) and spinal circuitry. Using microstimulation in 
developing animals and in maturity, small territories of cortex that are approximately 500 
µm in diameter (Keller 1993) show a preponderance for controlling a single or small set 
of limb muscles (Nudo and others 1992; Martin and Ghez 1993; Chakrabarty and Martin 
2000). Over the years considerable progress has been made in developing 
microstimulation techniques for more refined and discrete activation of descending 
neurons (Asanuma and Sakata, 1967). This effort has culminated in with methods capable 
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of detecting the excitatory and inhibitory effects of single neurons on muscle activity in 
the awake animal during task performance (Fetz 1976). 
Motor maps adapt in response to motor learning, therefore can serve as a 
surrogate marker for changes in motor behavior such as those observed during learning or 
rehabilitation. Several studies have demonstrated that motor training can induce changes 
in motor map organization that reflect the nature of the acquired skill. Nudo and 
colleagues have shown that training squirrel monkeys on a skilled digit manipulations 
task causes an expansion of digit representations (Nudo, Milliken 1996). It is important to 
note that ICMS-evoked movements may result from both direct excitation of local 
neurons and polysynaptic activation of more distant neurons. It is possible that the mosaic 
representations of movement as defined by the ICMS technique are at least partially a 
result of complex excitatory and inhibitory effects on spinal motoneurons arising from a 
relatively wide area of cortex. Nevertheless, the relative stability of the response at a 
given site, the striking differences in response between adjacent sites, and the correlation 
of ICMS defined boundaries with cytoarchitectonic boundaries suggest that ICMS is a 
reliable technique for defining functional boundaries in motor cortex (Huang et al 1988; 
Nudo 1990). Multiple muscles may be represented in at a single site in the primary motor 
distal forelimb representation. Fetz demonstrated that the output of a single cortical 
neuron typically facilitates multiple muscles. Using anatomical techniques in cats, 
Shinoda et al., 1981 have identified individual corticospinal neurons that project to 
multiple spinal cord segments, suggesting that some corticospinal neurons may project to 
multiple motoneuron pools. 
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1.7.2 Skilled reach training drives motor cortical plasticity. In these dissertation 
studies a skilled learning task was used as both an outcome measure and as a 
behavioral/therapeutic manipulation. Motor skills training in animals induces plastic 
changes in the motor cortex contralateral to the trained forelimb, including increase in 
dendritic arborization (Greenough 1985) and synapses (Kleim et al., 2004) and an 
expansion of motor representations devoted to reaching movements (e.g., digit and wrist, 
(Kleim, Barbay, & Nudo, 1998). It has been further established that practice with a 
skilled motor task (and not simple bar pressing task) is necessary to induce motor map 
reorganization (Kleim et al., 1998). Practice with skilled reaching in humans has also 
been shown to be associated with changes in motor cortical movement representations, as 
measured using transcranial magnetic stimulation (TMS) (Ziemann, Muellbacher, Hallett, 
& Cohen, 2001) and functional magnetic resonance imaging (fMRI) (Perez et al., 2007). 
 
1.7.3 Learning induced structural plasticity within M1. The functional adaptation in 
Motor cortex (M1) that accompanies motor skill learning depends on restructuring of 
motor cortex microcircuitry. In rats trained to reach, pyramidal neurons (PMN) in layers 
II/III and V have enlarged dendritic fields (Greenough, 1985; Greenough & 
Withers1989). This enlargement of dendritic surface is accompanied by an increase in the 
number of synapses per neuron in layer V PMNs suggesting that learning promotes 
synaptogenesis. This was confirmed by Kleim et al (1996) in a study showing an increase 
in the number of synapses/neuron occurred during the early phase of skilled reach 
training. Further, the increased synapse number was colocalized with an increase in distal 
forelimb representations (Kleim et al., 1998). Rioult-Pedotti and coworkers showed that 
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motor skill learning is associated with LTP like synaptic plasticity in rats.  Acquisition of 
a reaching task induced a long-lasting increase in synaptic strength in horizontal 
connections of layer II/III in the M1 forelimb representation contralateral to the trained 
paw. Similar results were obtained in an in vivo animal model (rat) introduced by Monfils 
and Teskey (2004). 
 
1.8 Behavioral and cortical changes following unilateral sensorimotor cortex 
damage 
Neuronal cortical connections can be remodeled by our experience was suggested by 
Hebb half a century ago. Since then, many studies have demonstrated chemical and 
anatomic plasticity in the cerebral cortex of adult animals. Unilateral SMC damage has 
been shown to result in profound sensory and motor impairments in the contralesional 
forelimb, including deficits in skilled reaching (Gilmour, Iversen, O'Neill, & Bannerman, 
2004; Whishaw, 2000), delayed responsiveness to tactile-stimulation ((Napieralski, 
Banks, & Chesselet, 1998), decreased use of this limb in tests of postural support  
(Adkins, Voorhies, & Jones, 2004; Allred & Jones, 2004) and increased errors in 
measures of coordinated limb use (Bury & Jones, 2002). Following SMC damage, a 
deficit in skilled reaching performance has been found to occur in rats (Gharbawie, Auer, 
& Whishaw, 2006; Gilmour, et al., 2004; Whishaw, 2000), in monkeys (Friel & Nudo, 
1998; Nudo, Wise, SiFuentes, & Milliken, 1996) and in humans (Green, 2003).  
 
1.8.1 Synaptic Plasticity in the Peri-infarct Cortex. Studies have shown that 
alternations in electrophysiological properties of motor cortex neurons contribute 
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significantly to network reorganization after stroke. Hagemann and colleagues reported 
enhanced long-term potentiation (LTP) in the peri-infarct zone around a photothrombotic 
lesion to primary somatosensory cortex (S1) (Hagemann et al., 1998). Neurons in the 
peri-infarct cortex (PIC) are more excitable after a stroke because NMDA-receptor 
expression is upregulated (Kalia et al., 2004) and GABAA- receptors are downregulated 
(Zilles et al., 1996). Reducing inhibition by blocking GABA-A-receptors is usually a 
prerequisite for the induction of LTP in vitro. Therefore increased cortical excitability 
might be a plausible explanation for facilitated LTP in the PIC. 
Mechanisms involved in learning motor skills task may share some similarities 
with those involved in LTP, an artificial means of inducing synaptic strengthening. Motor 
skills training results in LTP-like effects in the cortex opposite to the trained forelimb 
(Monfils, VandenBerg, Kleim, & Teskey, 2004; Rioult-Pedotti, Friedman, Hess, & 
Donoghue, 1998). LTP can be induced in motor cortex in awake animals (e.g., (Monfils 
& Teskey, 2004). LTP is thought to occur via strengthening of horizontal connections in 
the stimulated hemisphere (Hess, 1994) and is dependent on protein synthesis (Luft et al., 
2004).  Kleim and colleagues (2003) have shown that, following protein synthesis 
inhibition reorganized motor map representations are eliminated and synapses are lost in 
the same region, effects which were replicated by Hsu and colleagues (2007).  
 
1.8.2 Disrupting Cortical Circuitry. Studies in animals have shown that disrupting 
motor maps, without explicitly damaging the supporting cortex, causes an inability to 
produce skilled limb movement but does not abolish movement. For example, focal 
ischemic insult can cause a loss of movement representation within intact regions of the 
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motor cortex distal to the infarction. The disappearance of movement representations is 
accompanied by skilled movement impairments but not a total absence of movement 
(Nudo 1996). The loss of motor map is thought to be the result of neuronal dysfunction 
and a disruption of cortical circuitry, as there is a loss of synapses but not neurons within 
these regions (Kleim 2003). Effect likely mediated via changes in intracortical synaptic 
efficacy. Similar results have been found with pharmacological agents known to mediate 
synaptic plasticity within the motor cortex.  
 
1.8.3 Disruption of Synaptic Plasticity in Peri-infarct Cortex. Motor skill training 
induces synaptic plasticity (Kleim et al., 2002) and an expansion of motor maps in the 
motor cortex opposite the trained forelimb (Nudo, 2003; Kleim et al., 1998; Monfils et 
al., 2005). The ability for motor maps to reorganize is related to strengthening of synaptic 
connections, which is experience dependent (e.g., Kleim et al., 2002). The reorganization 
of peri-lesion cortex after stroke, including reorganization of motor maps, has been linked 
with functional recovery (e.g., Nudo, 2003). Conversely, increased activity in intact 
cortex, evident following unilateral brain damage (Que et al., 1999; Reinecke et al., 1999; 
Murase et al., 2004), is related to greater inhibition and disruption of peri-lesion cortex 
and poorer recovery (Murase et al., 2004).  
 
1.8.4 Interhemispheric connectivity of the SMC. There is converging evidence that 
the two cerebral hemispheres have a balance of activity that can be disrupted following 
unilateral brain damage. The SMCs of the two hemispheres interact via transcallosal 
inputs, which mediate interhemispheric inhibition and excitation (Lee, Gunraj, & Chen, 
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2007). Transcallosal inputs make excitatory connections onto pyramidal neurons of the 
opposite cortex (Chapin, Sadeq, & Guise, 1987; Karayannis, Huerta-Ocampo & Capogna 
2007, Carr & Sesak, 1998; Cisse, Grenier, Timofeev, & Steriade, 2003) and also project 
onto GABAergic inhibitory interneurons (Perez & Cohen, 2008; Innocenti, Clarke, & 
Kraftsik, 1986). Bilateral and intercortical activity occurs as a response to unilateral 
sensory stimulation (Liepert, Havernick, Weiller, & Barzel, 2006) and movement (Cisek, 
Crammond & Kalaska, 2003; Brus-Ramer, Carmel & Martin, 2009). Previously, the 
SMC region damaged in these studies was shown to receive transcallosal input from the 
opposite cortex, as reflected in biodextrine-amine (BDA) labeled axons (Bury & Jones, 
2004). Layer V pyramidal neurons also make synaptic connections with ipsilateral and 
contralateral striatums (Cospito & Kutlas-Ilinkshy, 1981).  
In humans, following stroke there is an increased inhibitory drive (as measured 
using a paired pulse TMS paradigm) from the contralesional to the lesion cortex (Duque 
et al., 2005; Perez & Cohen, 2009). This has also been shown to be correlated with a 
reduction in reaction time on a finger tapping task (Murase et al., 2004). Callosal lesions 
and agenesis of the corpus callosum in humans results in a loss of interhemispheric 
inhibition (Meyer, Roricht, Grafin von Einsiedel, Kruggel, & Weindl, 1995), which 
strongly suggests that interhemispheric activity is mediated through the corpus callosum. 
A disruption of interhemishperic activity following unilateral damage may become 
exaggerated with behavioral experience, and it stands to reason that if this unbalance is 
blocked, e.g., by callosal transections, this would prevent activity in the intact hemisphere 
from disrupting the ability of the lesion cortex to recover.  
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1.9 Compensation vs. Recovery in rats following cortical ischemia 
The interaction of both hemispheres after an ischemic injury may result in 
changes in motor performance via several mechanisms: restitution, substitution, or 
compensation (Carmichael, 2005). Levin and co-workers,however, distinguished motor 
recovery and motor compensation in accordance with the WHO International 
Classification of Functioning, Disability and Health framework and proposed that motor 
recovery relates to: restoration of function in neural tissue that was initially lost; 
restoration of ability to perform movement in the same way as before injury; and 
successful task completion as typically done by individuals who are not disabled. Types 
of motor compensation in these three areas include the acquisition by neural tissue of a 
function that it did not have before the injury; performance of a movement in a new way; 
and successful task completion by use of different techniques (Levin, Kleim & Wolf, 
2008).  
In an effort to delineate recovery vs compensatory behavior, behavioral scientists 
have developed a comprehensive testing battery that may be divided into two categories, 
based on whether they involve endpoint measures demonstrating how well are the 
animals doing the task, or qualitative measures indicating how the task is being done. 
Examples of endpoint measures are accuracy in reaching, number of strands of pasta 
obtained, or number of foot faults, whereas qualitative measures examine the normality 
of motor elements in a single reaching movement (Kleim et al, 2007). The use of these 
two different measures makes it possible to differentiate between true recovery of motor 
function as opposed to the development of compensatory motor strategies. For example, 
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increases in accuracy on a skilled reaching task may result from restoring the movement 
sequence used before the insult, developing a completely new movement sequence, or 
some combination of the two. The neural mechanisms that underlie restoration of the 
original movement sequence are likely very different from those involved in development 
of a completely new motor pattern. Analysis shows that improvements in reaching 
accuracy after stroke are due, at least in part, to adaptations in the original movement 
sequence (Gharbawie and Whishaw 2006). The strategy adopted in response to a given 
therapy may be influenced be any number of factors, including the size and location of 
the damage, the nature/efficacy of the rehabilitation treatment, or the timing of the 
treatment after insult. It is essential to understand the contribution of these factors in 
order to optimize the kind of rehabilitation administered to each patient. 
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Chapter 2 
NEUROTROPHINS AND CORTICAL PLASTICITY 
 The cerebral cortex is a rich source of neurotrophins that regulate the function of 
cortical neurons and cortical afferents (Cabelli et al. 1995; Lu et al. 2001; McAllister et 
al. 1995). Several lines of evidence suggest that neurotrophins may play a protective role 
in the pathophysiology of cerebral ischemia (Endres et al, 2000; Saarelainen et al, 2000; 
Yanamoto et al, 2000). Neurotrophins have also been shown to have a positive impact on 
the recovery of cortical projections after a cortical infarct (Figueiredo et al, 1993; 
Garofalo et al., 1992, 1993). In support of this hypothesis, several synaptically localized 
proteins have been identified and linked to changes in synaptic function (Martin and 
others 2000). One of the key neural signals involved in this process include neurotrophic 
factors such as brain derived neurotrophic factor (BDNF) that have been implicated in 
modulating dendritic morphology (McAllister, 1996; Tolwani 2002) and cortical map 
organization (Rocamora 1996). There is increasing evidence that brain-derived 
neurotrophic factor (BDNF) modulates synaptic and morphological plasticity in the 
developing and mature nervous system.  
 
2.1 Endogenous BDNF and TrkB receptors and its impact on possible downstream 
signaling mechanisms 
BDNF influences neuronal proliferation, survival, and differentiation as a result of 
binding to its tyrosine kinase receptor (TrkB). Both BDNF and tyrosine kinase receptor 
are widely distributed throughout the brain, with highest expression in the hippocampus. 
BDNF is considered to be a retrograde messenger. It is secreted from the pre-synaptic 
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cell and has both pre-synaptic and post-synaptic targets (Manabe, 2002). Neuronal 
activity stimulates BDNF release from pre-synaptic sites (Yamada and Nabeshima, 
2003). The secreted BDNF will bind to TrkB receptors on the pre-synaptic cell 
membrane and trigger an increase in pre-synaptic glutamate release. BDNF also binds to 
TrkB receptors on the post-synaptic membrane, which will become activated and trigger 
intracellular signaling cascades. Thus, increased neuronal activity enhances synaptic 
efficacy to increasing the transcription, secretion and binding of BDNF, which leads to 
enhanced glutamate release and activation of signal transduction pathways.  
 
2.2 Role of BDNF in enhancing neuroplasticity 
 BDNF has several important functions in the CNS. First, it promotes the 
differentiation and survival of a variety of neuronal populations during development and 
adulthood (Maness et al., 1994; Huang and Reichardt, 2001; Lu, 2003). Second, BDNF 
promotes neurite extension of sensory processes to their targets within the CNS (Maness 
et al., 1994). Finally, BDNF plays a crucial role in mediating synaptic plasticity and 
transmission (Lu, 2003). These BDNF-induced changes in synaptic plasticity can occur 
in an acute manner. For example, application of BDNF to the neuromuscular junction 
elicits a rapid enhancement of neurotransmitter release (Stoop and Poo. 1995). BDNF can 
also play a regulatory role in synapse development and function by triggering changes in 
the production of synaptic proteins (Corman and Berchtold, 2002) and by modulating 
growth/arborization of cortical dendrites (Horch and Katz, 2002).  
2.2.1 Structure and function of BDNF. BDNF is a basic protein with 119 amino acid 
residues in its structure (Maness et al., 1994). Although BDNF is primarily found in the 
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central nervous system (CNS), it is also produced in lesser quantities in Schwann cells of 
the peripheral nervous system (Acheson et al., 1991) and in organs such as the heart and 
lungs (Rosenthal et al., 1991). In the CNS, BDNF is widely distributed in a number of 
brain regions, including the hippocampus, striatum, cerebellum and substantia niagra 
(Maness et al, 1994). In the cerebral cortex, studies have shown BDNF to be primarily 
localized to layers III and V (Murer at al., 1999).   
 
2.2.2 TrkB Receptors. TrkB consists of an IgG-like extracellular domain that is essential 
for ligand binding. There are 6 kinase domains in the intracellular part of the receptor 
(Klein et al, 1990a). Binding of BDNF or NT4 to TrkB homodimers results in the 
autophosphorylation of their kinase domains and thus starts a signaling cascade (Marsh et 
al, 1993).  
TrkB is expressed in all neural tissues during embryonic development but shows 
restricted expression in specific regions and neuron types of the adult brain (Klein et al., 
1990b). It is expressed in both the pre- and post-synaptic compartments and is evenly 
distributed in primary hippocampal and cortical neurons (Kryl et al, 1999). TrkB is 
enriched in postsynaptic densities (Wu et al, 1996) and colocalizes with NMDARs in the 
dendrites and synaptic vesicles in the axons of cortical neurons (Gomes et al., 2006). 
Surface TrkB is found in dendritic filopodia and axonal growth cones, structures that take 
part in synapse formation. In addition to the full length TrkB receptor, two C-terminally 
truncated splice variants of TrkB have been identified - TrkB.T1 (Klein et al, 1990) and 
TrkB.T2 (Barbacid, 1994). TrkB, TrkB.T1 and TrkB.T2 share the same extracellular and 
transmembrane domains and the first 12 amino acid sequences of the intracellular 
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domain. The truncated isoforms lack the kinase domain of the TrkB and instead have 
isoform specific C-terminal sequences (11AA for TrkB.T1 and 9AA for TrkB.T2). 
Although TrkB.T1 receptors form homodimers upon ligand binding, downstream 
signaling does not occur due to the lack of functional kinase domains. Along with TrkB, 
TrkB.T1 is expressed in dendrites and axons of cortical and hippocampal neurons, with 
moderate enrichment in postsynaptic densities (Kryl et al, 1999).  
 
2.2.3 MAPK, AKT/ERK, PI3K. BDNF primarily supports the function of glutamatergic 
neurons and preferentially binds to the TrkB tyrosine kinase receptor on these neurons 
(Cotman and Engesser-Cesar, 2002). Following ligand binding, the TrkB receptor 
autophosphorylates, which leads to activation of the tyrosine kinase and thus the 
activation of the receptor itself (Huang and Reichardt, 2001). Once activated the receptor 
is capable of triggering a number of intracellular signaling cascades, including the 
phosphatidylinositol-3-kinase/protein kinase B (PI-3-K/PKB), the phospholipase C-γ1 
pathway and the MEK/extracellular signal-regulated kinase (ERK) systems (Kaplan and 
Miller, 2000). The ultimate results of these pathways are both short term (enhancement of 
glutamate release) and long term (activation of transcription factors in the nucleus that 
alter gene expression) (Kaplan and Miller, 2000).  
 
2.2.4 C-AMP Response Element-Binding Protein (CREB). One MEK/ERK-activated 
transcription factor that may be especially important to BDNF-induced neuroprotection is 
cAMP response element-binding protein (CREB). CREB is also activated by components 
of other intracellular signaling pathways, including protein kinase C, Ca2+ calmodulin 
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kinase and ribosomal S6 kinase 2 (Walton and Dragunow, 2000). CREB has been 
described as the genetic switch that regulates the expression of genes necessary for the 
establishment of long-term synaptic plasticity (Alberini, 1999). It is involved in other 
aspects of neuronal functioning, including neuronal excitation (Moore et al., 1996) and 
development (Imaki et al., 1994). In addition, CREB has been linked to cell survival. 
Several studies have shown that activated CREB promotes cell survival while inhibition 
of CREB phosphorylation triggers apoptosis (Bonni et al., 1999; Walton and Dragunow, 
2000; Jaworski et al., 2003). CREB may also play a crucial role neuronal survival 
following ischemia (Walton et al., 1996; Jin et al., 2001).  
It is interesting to note that CREB is also able to activate the BDNF gene directly, 
thus promoting BDNF protein synthesis (Shieh et al., 1998; Tao et al., 1998). As 
suggested by Walton et al (2000), the CREB-regulated transcription of the BDNF gene 
may represent a positive feedback loop that may operate in some cell populations to 
promote resistance to brain injury. Both CREB (Alberini, 1999) and BDNF (Lu, 2003) 
have been linked to synaptic potentiation; thus they may act to promote the reduction of 
diaschisis in peri-infarct tissue by preventing dysfunctional synaptic transmission. 
 
2.2.5 Mechanism and regulation of BDNF action. The ability of BDNF to mediate 
synaptic modulation is dependent upon synaptic activity (Lu, 2003). Thus increased 
electrical activity in the cells is proposed to up-regulate BDNF, which in turn facilitates 
synaptic plasticity (Cotman and Berchtold, 2002). Increased neuronal activity can be 
initiated by several different types of stimuli, including experimentally induced seizures 
(Ernfors et al., 1991), tetanic stimulation (Morimoto et al., 1998) and physical activity 
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(Neeper et al., 1996) and each has been shown to up-regulate BDNF mRNA levels in the 
brain. Further, increased neuronal activity increases the number of TrkB receptors 
expressed on the presynaptic neuron (Meyer-Franke et al., 1998).  
BDNF is considered to be a retrograde messenger. It is secreted from the pre-
synaptic cell and has both pre-synaptic and post-synaptic targets (Manabe, 2002). 
Neuronal activity stimulates BDNF release from pre-synaptic sites (Yamada and 
Nabeshima, 2003). The secreted BDNF will bind to TrkB receptors on the pre-synaptic 
cell membrane and trigger an increase in pre-synaptic glutamate release. BDNF also 
binds to TrkB receptors on the post-synaptic membrane, which will become activated and 
trigger intracellular signaling cascades. Thus, increased neuronal activity enhances 
synaptic efficacy to increasing the transcription, secretion and binding of BDNF, which 
leads to enhanced glutamate release and activation of signal transduction pathways. 
 
2.2.6 BDNF/TrkB and Brain Injury. Given the beneficial effects of BDNF in the brain, 
it has been hypothesized that BDNF could be a viable treatment to ameliorate damage 
from various forms of brain injury. There is an abundance of research supporting this 
idea. (Yanamoto et al, 2000) found that pretreatment with BDNF prior to temporary focal 
ischemia significantly reduced infarct volume. Schabitz et al. (2002) found that BDNF 
delivered intravenously following focal cerebral ischemia reduced infarct volume and 
neurological deficits. In addition, these authors also found that the expression of 
proapoptotic protein Bax was decreased, while expression of antiapoptotic protein Bcl-2 
was increased, which may be one mechanism by which BDNF exerts its neuroprotective 
action. Finally Wu and colleagues (Wu et al, 2003) found that low BDNF mRNA levels 
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are related to poor recovery of spatial memory and impairments in motor performance 
following traumatic brain injury. BDNF is stored and released from glutamate neurons in 
a use-dependent fashion and has been implicated in long-term potentiation, learning, 
memory formation, depression, and recovery from brain injury. Administering BDNF in 
the acute post-ischemic period reduces cell death and delayed treatment facilitates motor 
recovery in rats.  Finally, among survivors of hemorrhagic stroke, patients with the Met 
allele of the BDNF val66met polymorphism show significantly worse functional outcome 
than patients without the allele (Siironen et al., 2007). Together these data suggest that 
the TrkB signaling pathway is involved in mediating motor recovery and concomitant 
cortical plasticity after stroke. 
 
2.3 Protein synthesis and motor skill learning  
Neurotrophins are a family of vertebrate specific growth factors that are critically 
involved in regulating neuronal survival and differentiation in development and continues 
to shape neuronal structure and function throughout life (Castrén, Zafra, Thoenen, & 
Lindholm, 1992; Dechant, 2001; Prakash, Cohen-Cory, & Frostig, 1996). The 
receptor/ligand systems used to mediate these effects involve four genes encoding four 
ligands (NGF, BDNF, NT3 and NT4/5) and four genes encoding four receptors (TrkA, 
TrkB, TrKC and p75). TrKB receptors are the most generalized, binding to three of the 
four ligands (BDNF, NT3 and NT4/5) and mediate intracellular signaling via a receptor 
tyrosine kinase pathway. One of the key functions of the TrkB receptor is to bind BDNF. 
TrkB-mediated signaling pathways have been tested in vivo by mutating the recruitment 
site, Y816, to phenylalanine (Minichiello et al., 2002). Electrophysiological experiments 
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show that the TrkB mutant mice have significant deficiencies in the induction of both the 
early and late phases of hippocampal CA1 long-term potentiation (LTP), an artificial 
means of inducing synaptic strengthening (Huang and Reichardt 2003). Phosphorylation 
of CREB is severely impaired in these neurons. Trk receptor signaling also controls the 
activity and localization of neurotransmitter receptors through protein phosphorylation. 
For example, BDNF, activation of TrkB promotes the phosphorylation and 
dephosphorylation of the NMDA receptor subunit NR2B with phosphorylation increasing 
the open probability of the NMDA receptor ion channel and thereby rapidly enhancing 
synaptic transmission (Levine et al., 1998; Lin et al., 1999). In addition to these acute 
effects of Trk activation, additional deficits are seen in mice lacking normal TrkB-
mediated signaling. These include reductions in vesicles docked at release sites and 
reduced expression of synaptic proteins (Pozzo-Miller et al., 1999). 
BDNF has been demonstrated to modulate synaptic strength and neuronal 
excitability. BDNF expression is regulated in an activity dependent manner at different 
molecular levels (Bengzon et al., 1993; Pattabiraman et al., 2005; Rossi et al., 1999). It 
has been demonstrated that cellular mechanisms behind learning-related plasticity in the 
motor cortex (M1) appear to depend on protein synthesis within this structure and may 
specifically involve brain-derived neurotrophic factor (Kleim et al., 2003).  In both 
humans and animal models, BDNF influences synaptic plasticity (Akaneya et al., 1997; 
Lu, 2003) resulting in reorganization of cortical circuitry such that the muscles 
controlling trained movements are more easily evoked in response to cortical stimulation.  
Mechanisms involved in learning motor skills task may share some similarities 
with those involved in LTP. LTP can be induced in motor cortex in awake animals (e.g., 
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(Monfils & Teskey, 2004). Motor skills training results in LTP-like effects in the cortex 
opposite to the trained forelimb in rats (Monfils, et al., 2004; Rioult-Pedotti, et al., 1998). 
LTP is thought to occur via strengthening of horizontal connections in the stimulated 
hemisphere (Hess, 1994) and is dependent on protein synthesis (Luft et al., 2004).  Kleim 
and colleagues (2003) have shown that, following protein synthesis inhibition 
reorganized motor map representations are eliminated and synapses are lost in the same 
region, effects which were replicated by Hsu and colleagues (2007). Moreover, training-
dependent increases in motor cortical excitability (Antal et al., 2010; Cheeran et al., 
2009) and Functional Magentic Resonance Imaging (fMRI) signal (McHughen et al., 
2010) are reduced in healthy humans with a valine-to-methionine substitution at codon 66 
(Val66Met) in the BDNF gene, when compared to subjects without this polymorphism 
(Kleim et al., 2006).These findings also lead to the hypothesis that BDNF is involved in 
mediating experience-dependent plasticity of human motor cortex and the presence of 
this particular polymorphism could influence motor skill learning. Relearning motor 
skills after stroke is multifaceted incorporating or relying on spatial context, retrieval of 
previously learning movement strategies, motivation, working memory, and internal and 
external sensory feedback (Corbett 2009). Therefore, strategies that increase BDNF, 
broadly within the nervous system, may enhance neuroplasticity processes in multiple 
neuronal systems involved in motor relearning during stroke rehabilitation. 
 
2.4 Limitations of using BDNF as a pharmacological intervention 
The beneficial role of BDNF in the brain makes it a viable therapeutic candidate. 
However, BDNF when administered in its native form itself exhibits a poor 
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pharmacokinetic profile with a short plasma life and a low permeability through the 
blood brain barrier. BDNF interacts with both the TrkB and with p75 receptor (Chao 
&Hempstead, 1995). Activation of the p75 receptor can result in many undesired side 
effects such as pain (Zhang, Chi, & Nicol, 2008) and apoptosis (Barrett et al. 2000). Of 
the two receptors, TrkB is an essential modulator of neural plasticity and activation of 
TrkB has been shown to be essential for the survival-promoting actions of BDNF 
(Reichardt, 2006). Hence, there is a critical need to develop interventions that would up 
regulate endogenous signaling by pharmacologically harnessing the beneficial synaptic 
effects of BDNF that would help restore lost functions after stroke. 
 
2.5 Development of novel TrkB receptor agonists 
In an effort to overcome the limitations presented by BDNF in its use as a 
pharmacological agent, several researchers have developed compounds that mimic the 
role of BDNF by binding to TrkB receptor and activating downstream signaling pathways 
through phosphorylation of catalytic sites of TrkB receptor. Further, these compounds 
were developed to reliably cross the blood brain barrier in an effort to make them more 
clinically viable. 
2.5.1 7,8 Dihydroxyflavone. 7,8 Dihydroxyflavone is a synthetic flavonoid derivative, 
which selectively binds to TrkB receptor and stimulates receptor dimerization, a function 
similar to BDNF (Jang et al., 2010).  
2.5.2 LM22A-4. Another recently discovered compound, LM22A-4 (N,N’,N’-tris (2-
hydroxyethyl)-1,3,5-benzene tricarboxamide), a small molecule ligand designed to mimic 
the loop II domain of BDNF (Massa et al., 2010) has been shown to 1. Selectively mimic 
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the cell signaling actions of BDNF on the TrkB receptor, actively cross the blood brain 
barrier, and enhance functional recovery in animal models of several neurological 
disorders (Han et al., 2012; Schmid et al., 2012). LM22A-4’s effects are qualitatively and 
quantitatively different than the native BDNF protein (Massa et al., 2010).  
Efficacy of these two compounds was tested in a rodent model of cortical 
ischemia, whose findings will be discussed in the following chapters.  
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Chapter 3 
7,8 dihydroxyflavone enhances motor performance and partially 
restores forelimb movement representations following cortical ischemia 
3.1 Introduction 
Stroke remains the leading cause of adult disability with prominent functional 
motor deficits in surviving stroke victims. Motor recovery after stroke can be thought of 
as a “relearning” process whereby lost motor functions are reestablished through 
functional restoration and compensation (plasticity) within spared motor brain regions. 
Identifying and harnessing the neural signaling systems that drive both neural plasticity 
and motor learning can be used to guide the development of adjuvant treatments to 
enhance motor recovery after stroke. 
Genetic, pharmacological and electrophysiological studies in a variety of 
organisms have demonstrated the importance neurotrophins such as Brain Derived 
Neurotrophic Factor (BDNF) for inducing synaptic plasticity (Lu, 2003), cortical 
reorganization (Maffei, 2002; Kleim et al., 2006) and learning (Yamada & Nabeshima, 
2003; Rattiner et al., 2004). This has led to the hypothesis that BDNF and the tropomysin 
related kinase receptor (TrkB) is a key neural signal driving rehabilitation-dependent 
motor recovery and cortical plasticity after stroke.BDNF appears to be a powerful 
therapeutic tool. However, clinical trials using recombinant BDNF failed because of 
enzymatic degradation, poor delivery, and other limitations (Ochs et al., 
2000 and Thoenen and Sendtner, 2002).  
Emerging evidence suggests that dietary phytochemicals, in particular flavonoids, 
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may exert beneficial effects in the central nervous system presumably by protecting 
neurons against stress-induced injury, by suppressing neuroinflammation and enhancing 
existing neurocognitive performance, through changes in synaptic plasticity (Spencer, 
2007). Flavonoids, found in plants and fruit, exert anti-oxidative effects and have 
demonstrated reactive oxygen species (ROS) scavenging abilities (Schroeter et al., 2002; 
Mandel et al., 2004; Williams et al. 2004).  
Previous studies have highlighted that modulations of mitogen-activated protein 
kinase (MAPK) signaling are central to mediating the cellular effects of flavonoids 
(Schroeter et al. 2002; Williams et al. 2004). The role of flavonoids has also been 
implicated in regulating AKT and phosphorylation of extracellular signal-regulated 
kinase (ERK) signaling pathways (Schroeter et al. 2007). One of the major receptors 
through which these cellular effects are initiated in the brain has been identified to be 
tyrosine kinase receptors. Trks are activated by binding of mature neurotrophin dimers 
and multimerization, leading to phosphorylation and signaling adaptor recruitment 
(Huang & Reichardt, 2003).  
Flavonoids are well reported to cross the blood-brain barrier (BBB), but the extent 
of permeation is low depending on compound’s lipophilicity (Yodium et al. 2004, 2003). 
Many efforts have been directed at circumventing these problems and recently, an 
exogenous agent, so-called 7,8-DHF, was identified as a potent and selective TrkB 
receptor agonist, mimicking Brain Derived Neurotropic Factor (BDNF).  
Mechanism: The basal structure of flavonoids consists of 15 carbon atoms with two 
terminal aromatic rings linked through an oxygenated heterocycle (C6-C3-C6) (Beecher, 
2003). Flavonoids can be divided into six main classes (flavanols, flavanones, flavones, 
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isoflavones, flavonols and anthocyanidins). Because of their hydroxyl groups, flavonoids 
stabilize ROS by interacting with the reactive compound of the radical according to the 
following reaction:  
                FOH    +    R`   FO`   +     RH 
 where FOH is flavanoid, R` is free radical, and FO` is less reactive free radical.  
The purpose of this study was to investigate the efficacy of 7,8 Dihydroxyflavone 
for reducing behavioral and neurophysiological impairments associated with cortical 
ischemia in rats. Rats use their forepaws in dexterous ways that are in some capacities 
homologus to humans (Iwaniuk and Wishaw, 2000). And there is a growing appreciation 
that forepaw movements provide a useful model for probing aspects of hand function and 
dysfunction. Rats skillfully manipulate the food with the movements of the forepaws, 
including fine digit movements. It has long been known that CNS damage can influence 
the way rodents grasp and handle food (Peterson & Mc, 1951) and (Castro, 1972). Motor 
learning and plasticity have been associated with TrkB and/or BDNF expression in the 
cortex (Klintsova, Dickson, Yoshida, & Greenough, 2004). BDNF has also been reported 
to improve motor recovery and increase measures of neuronal remodeling after cortical 
ischemia (Schabitz et al., 2004). Because BDNF possesses a broad spectrum of 
physiological activities, and its dysregulation is involved in numerous neurological 
disorders, flavonoid-based TrkB agonists have the potential to be developed into a 
powerful class of therapeutic drugs (Jang et al., 2010). 7,8-DHF (Figure 3.1) is a 
synthetic compound, slightly modified from a naturally occurring version and is highly 
selective compared to BDNF with a dissociation constant of approximately 320nM. 
Therefore, it could possibly serve as an alternative to BDNF.  
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Figure 3.1 Structure of 7, 8-Dihydroxyflavone (Adapted from Jang et al., 2010). 
 
3.2 Methods 
3.2.1 Experiment 1. Twenty four, male adult (100-120 days of age) Long Evans rats 
were assigned to one of three conditions: 7, 8 DHF, (N=8); Vehicle, (N=8) and Healthy 
controls (N=8). Animals in the 7,8 DHF condition received 5mg/kg (i.p.) of 7,8 DHF, 2 
hours prior to inducing ischemia by topical application of endothelin-1 (ET-1) onto the 
frontalcortex. These animals then received 7,8 DHF daily for the next twenty-one days. 
Animals in the Vehicle condition were given similar cortical infarctions but received 
vehicle (30% DMSO) two hours prior and for the same duration of time. Controls 
animals did not receive infarctionsor the drug treatment. All animals were given 7 days to 
recover after surgery and motor impairments were assessed on a battery of forelimb 
motor tasks including cylinder paw placement, sunflower seed opening, and vermicelli 
handling for the next two weeks. Intracortical microstimulation (ICMS) was then used to 
map forelimb movement representations within the rostral and caudal forelimb areas of 
the ipsilesional motor cortex. Rats were euthanized using pentobarbatol, perfused and 
fixed in 4% paraformaldehyde. Histological analysis on brain sections was conducted to 
assess infarct volume.  
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3.2.2 7, 8 Dihydroxyflavone administration. For intraperitoneal administration 7,8-
DHF was dissolved in dimethyl sulfoxide (DMSO4) and phosphate buffer saline (PBS) 
was gradually added into the DMSO solution, to bring the final drug concentration to 
0.5mg/ml with 30% DMSO V/V. Rats were injected with 5mg/kg of 7,8-DHF.  
 
3.2.3 Cortical Ischemia. Animals were anesthetized under 4% isoflorane gas, at 40psi 
and maintained 1.5% isoflourane during the procedure and secured in a stereotaxic frame. 
The skull and dura were removed between 0.5 mm posterior and 1.5 mm anterior to 
bregma and 3.0-4.5 mm lateral to midline. Ischemia was then induced unilaterally in the 
proximity of middle cerebral artery by topical application of 4 µl vasoconstrictor, 
endothelin-1 (ET-1). ET-1 (80pmol) was aimed at the overlapping primary 
somatosensory and motor cortical representation regions of the forelimb. The skull was 
left undisturbed for ten minutes after ET-1 administration and Cerebral perfusion in the 
distribution of the middle cerebral artery was monitored throughout the surgical 
procedure with a laser Doppler (Perimed Inc.), and only animals with a >80% decrease in 
cerebral perfusion were included in this study. ET-1application. It provides continuous 
and real time measures of regional cerebral blood flow changes. The exposed cortex was 
then covered with kwik-sil, a translucent, medium viscosity silicone adhesive (37 °C). 
The scalp was sutured and rats were allowed to recover in their respective home cages.   
 
3.2.4 Behavioral Testing. Animals were given 7 days to recover after surgery and then 
assessed on forelimb behavioral testing battery. The tasks ranged from measures of gross 
motor performance to fine object manipulation. Forelimb tasks included sunflower seed 
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opening, vermicelli pasta handling, and cylinder paw placement. These tests are 
especially sensitive to detecting upper extremity dysfunction (Table 3.1). 
 
Table 3.1: Motor Test Battery 
 
 
 
Sunflower Seed 
Opening 
Cylinder Vermicelli  
Handling  
Time (secs) 
# Pieces 
# Wall touches 
# Landings 
# Adjustments 
# Time 
 
Table 3.1 Motor test battery of tasks assessing upper extremity function 
 
 
Figure 3.2 Schematic drawing of the experimental plan 
 
Sunflower seed opening test 
 Rats are inherently adept at opening shelled seeds to obtain food, and sunflower 
seed opening is an effective measure of bilateral object manipulation (Whishaw, Sarna, & 
Pellis, 1998) as well as a good detector of motor impairments after stroke (Gonzalez & 
Kolb, 2003). Each rat was placed in a rectangular Plexiglas chamber and given five 
sunflower seeds. Rats start by manipulating the seed into a preferred position before 
37 
shelling. They then chew away a corner of the seed in order to facilitate splitting it 
longitudinally and finally the seed is split open into two or more pieces. In this task the 
total amount of time it took the animal to manipulate, open and consume all five seeds as 
well as the number of pieces of shell the animal had to break to retrieve the seed was 
measured.  
Vermicelli handling task  
This test consisted of 4 trials with 7 cm long pasta pieces given one at a time per 
each trial. The experimental set up was similar to the one described in (Allred et al., 
2008). Data were collected with the rat facing the experimenter such that the digits and 
joints of the metacarpals and phalanges of both forepaws could be seen. The rats 
exhibited typical holding patterns, as previously described by (Whishaw & Coles, 1996).
 Eating time was recorded, beginning when the pasta piece was grasped and placed 
in the mouth and ending when the piece was released by the paws and disappeared into 
the mouth. Total number of paw adjustments made while consuming pasta for each trial 
were also recorded.  
Forelimb use asymmetry  
The Schallert cylinder test was used to examine asymmetries in forelimb use for 
postural support during explorative activity by placing each rat in a transparent cylinder 
20cm in diameter and 30 cm high for 3 min (Schallert, Fleming, Leasure, Tillerson, & 
Bland, 2000). This test encourages upright support against the cylinder wall, which 
sensitively reveals forelimb asymmetries. Rats were videotaped in the cylinder and then, 
during slow-motion video play back, instances of the sole use of the ipsilateral (to the 
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lesion) or contralateral forelimb or the simultaneous bilateral use of both forelimbs for 
upright support was recorded.  
Behavior was quantified by determining the occasions when the unimpaired 
(ipsilateral) forelimb was used as a percentage of total number of limb use observations 
on the wall; the occasions when the impaired forelimb (contralateral to the blood 
injection site) was used as a percentage of total number of limb use observations on the 
wall; and the occasions when both forelimbs were used simultaneously (or nearly 
simultaneously during lateral side-stepping movements) as a percentage of total number 
of limb use observations on the wall . The ipsilateral asymmetry score was computed 
using the formula: % (ipsilateral forelimb support+1/2 bilateral forelimb 
support)/(ipsilateral+contralateral+bilateral forelimb support). Forelimb placement during 
rearing, wall exploration and landings were recorded to determine forelimb asymmetry. 
 
3.2.5 Mapping Procedure. Intracortical microstimulation (ICMS) techniques were used 
to generate detailed ipsilesional maps of forelimb regions of the motor cortex. Prior to 
surgery animals were anesthetized with ke7,8 DHF tamine hydrochloride (70 mg/kg 
intraperitoneally [i.p.]) and xylazine (5 mg/kg i.p.). Animals received supplemental doses 
of ketamine (20 mg/kg i.p.) and xylazine (0.02 mg/kg i.p.]) as needed. A digital image of 
the cortical surface was taken and a 500-µm grid was superimposed onto the image. A 
glass microelectrode (controlled by a hydraulic microdrive) was used to make systematic 
penetrations across the cortex using the cortical surface image and grid as a guide. At 
each penetration site, the electrode was lowered to approximately 1550 µm 
(corresponding to cortical layer V). Animals were maintained in a prone position with the 
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limb consistently supported. Sites where no movement was detected at ≤60 µA were 
recorded as unresponsive. Forelimb movements were classified as either distal 
(wrist/digit) or proximal (elbow/ shoulder) and representational maps were generated 
from the pattern of electrode penetrations (Fig. 5a). An image analysis program 
(CANVAS v. 3.5) was used to calculate the areal extent of the CFA. Briefly, each map 
was imported into CANVAS and calibrated to magnification. Individual areas were 
traced using the marquis tool to produce a measure of area (mm2). 
 
3.2.6 Histology and lesion verification. Rats were given an overdose of sodium 
pentobarbital and intra-cardially perfused with 0.9% saline followed by 4% 
paraformaldehyde solution immediately after mapping. The brains were removed and 
post fixed in 4% paraformaldehyde solution for 24-48 hrs and then finally placed in a 
30% sucrose-formalin solution for 3 days before being cut frozen on a microtome. The 
brains were sectioned coronally at a thickness of 40µm. Sections were collected in a 
chilled 0.1M phosphate buffer solution and one series of every seventh section from the 
cortex and the sub-cortex was mounted on subbed slides and stained with cresyl violet to 
demonstrate Nissl substance (Morecraft, Geula, & Mesulam, 1992). Myelin staining was 
also carried out in the same sections. The mounted sections represented every 240-µm 
intervals in an individual series of tissue sections on the slides. Infarct size was 
determined by measuring areas of noninfarcted tissue in both the damaged and 
undamaged hemispheres. Lesion volumes were indirectly estimated based on 
interhemispheric volume differences by tracing whole cerebral hemispheres in sections 
440 µm apart using Image J software. 
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3.2.7 Experiment 2: 
2A. The potential effects of 7,8 DHF on vasodilation were investigated through measures 
of cortical blood perfusion using PeriCam PSI system (PeriMed). Four animals received 
7,8-DHF (5mg/kg; i.p.) and four received vehicle (30% DMSO; i.p.) 2 hours prior to 
ischemic injury. Cortical blood flow measures were recorded in anesthetized rats starting 
10 mins pre topical ET-1 through 90 mins post ET-1. 
2B: The effects of 7,8 DHF treatment on pTrkB protein expression was assessed using 
Western blot analysis. Healthy Long Evans rats (120 days old) were used in this 
experiment. 5 rats received 7,8-DHF (5mg/kg; i.p.) and 5 received vehicle (30% DMSO; 
i.p.) once a day for 7 consecutive days up to 2 hours prior to being sacrificed.  
Western Blotting 
 Rats were killed by rapid decapitation, and the brains were removed from the 
skull. Frontal cortices and hippocampi were removed. Protein extracts were subjected to 
Western blot analysis using standard techniques with slight modifications (Han et al. 
2012). Blots were probed with antibodies recognizing pTrkB-Y817 (rabbit mAb 
1:30,000, Epitomics), TrkB (rabbit polyclonal antibody1:2500, Millipore), and HRP goat 
anti-rabbit (1:10,000, Pierce Biotechnology). GAPDH (14C10) (rabbit mAb 1:10,000) 
was used a loading control. Optical densities were measured using LiCor Odyssey 
Infrared imaging system. Ratios were calculated as pTrkB over full length TrkB receptor 
and data was normalized to saline-treated stroked rats.  
3.3 Results 
3.3.1 Statistical analysis. Behavioral data from lesion studies were analyzed using 
univariate analyses of variance (ANOVA) for all measurements. Fisher’s protected least 
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significant difference (LSD) (p < 0.05) post hoc statistical measures were computed to 
determine group differences in behavioral results by treatment. A modified LSD was 
used because Fisher’s LSD does not account for multiple comparison and severely 
inflates Type 1 error (i.e., finding a difference when it does not actually exist). Protected 
Fisher’s LSD allows all pairwise comparison among means and if the analysis of 
variance is significant, then each mean is compared with each other using a t-test. All 
descriptive statistics are reported as means ± S.E.M. unless otherwise indicated. The 
significance levels were * p< 0.05,  
** p< 0.03. 
 
3.3.2  7,8 DHF treated rats showed reduced motor impairments in comparison to 
vehicle injected rats on sunflower seed opening task, but not on cylinder or 
vermicelli handling tests 
Sunflower Seed Test. In order to assess fine digit manipulation the sunflower seed 
opening test was conducted for two consecutive days a week after the injury. The mean 
time to consume the seeds in healthy control rats was 55.31± 3.92 s, averaged over the 
population examined. 7, 8 DHF treated group took 65.18 ± 6.9 s to complete the task 
whereas the vehicle treated group took the longest, 152 ± 47.25 s to consume all five 
seeds in the chamber (Figure 3.3). A univariate ANOVA comparison of multiple groups 
showed a significant main effect of the drug between 7,8 DHF and the vehicle group 
(F=3.74, P = 0.037), control group and vehicle injected groups also differed significantly 
(p = 0.021).  
42 
 
Figure 3.3 Sunflower seed opening test. Average time taken to consume 
five sunflower seeds: (Healthy control rats = 55.31 ± 3.92 s; 7,8 DHF 
group = 65.18 ± 6.9 s; vehicle group = 152 ± 47.25). Healthy control rats 
were better at fine digit manipulation during sunflower seed opening task 
and took the least amount of time in consuming the seeds, but 7,8-DHF 
treated rats showed less impairments by finishing the task significantly 
faster than the vehicle injected rats, (p < .05) 
 
Vermicelli Handling Test. In vermicelli handling, animals in the control group 
were faster taking 28.68 ± 3.71 seconds to consume 4 pieces of vermicelli pasta. 7,8-DHF 
treated group had an average of 52.7 ± 4.94 s, and vehicle injected rats consumed their 
pasta in 46.18 ± 6.47 s (Figure 3.4). A univariate ANOVA comparison of multiple groups 
showed a significant difference between lesioned and non-lesioned animals ((F=5.866, P 
= 0.03) Vehicle injected group did not differ from 7,8 DHF receiving group. 
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Fig 3.4 Vermicelli Handling Test. Average time to consume four pieces 
of vermicelli pasta: (Control=28.68 ± 3.71; 7,8-DHF=52.7 ± 4.94; 
Vehicle= 46.18 ± 6.47). A statistically significant difference (p < 0.05) 
was observed between stroke rats and the controls, no significant 
difference was observed between 7,8-DHF or vehicle treated groups 
during post-lesion testing. 
Cylinder Test. Compared with controls, stroke rats had marked forelimb use 
asymmetry. The forelimb use asymmetry score was not significantly different 
between7,8-DHF treated and vehicle receiving rats. Stroke animals preferred to use their 
non-impaired limb with a higher frequency than their impaired paw (Figure 3.5). Further, 
vehicle treated rats used their impaired limb to a lesser degree than 7,8-DHF administered 
rats, but the difference was not significant.  
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Figure 3.5 Cylinder test. Forelimb use asymmetries during cylinder wall 
touches.  7,8-DHF and Vehicle treated rats showed significantly reduced 
asymmetries compared to controls (p < 0.05). 7,8-DHF and Vehicle 
receiving rats use non-impaired limb significantly more than controls for 
weight bearing during wall explorations.  No statistically significant 
differences were observed between  7,8-DHF and Vehicle receiving 
animals. 
3.3.3 7,8-DHF treated rats showed greater forelimb motor map areas than vehicle 
treated animals 
Total forelimb area expressed in mm2 consisted of caudal and the rostral forelimb 
representations. Over all, healthy controls (N=7) had the largest forelimb area of 7.01 ± 
0.865 mm2. 7,8 DHF group (N= 5) had an average total forelimb representation of 2.48 ± 
0.81 mm2 and vehicle group (N=6) had 0.189 ± 1.4 mm2 area representing the forelimb 
function (Figure 3.6). A univariate ANOVA comparison revealed a significant effect of 
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group ((F= 25.9, P = 0.000). Follow-up tests (LSD), showed that 7,8 DHF treated group 
had larger map area than the vehicle injected group (p = 0.04).  Motor maps of the 
ipsilesional sensorimotor cortex displaying proximal and distal forelimb representations 
are shown in Figure 3.7.  
 
 
Figure 3.6 Forelimb area determined by ICMS. Area of caudal and 
rostral forelimb regions on the sensorimotor cortex in vehicle, 7,8-DHF 
and control rats. Forelimb motor maps are significantly reduced in vehicle 
receiving rats compared to 7,8-DHF receiving rats (p < .05).  
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Figure 3.7 Total forelimb representation. Representative ipsi-lesion 
motor maps of caudal and rostral forelimb areas from a Control, Vehicle, 
and 7,8-DHF and Vehicle treated rats. Forelimb motor map 
representations are shown in green (wrist/digit) and blue (elbow/shoulder).  
 
3.3.4 7,8 DHF treated animals had significantly smaller infarctions than vehicle 
treated animals 
Lesions were verified in histological coronal sections, as described previously. 
Sections were stained with myelin and cresyl-violet stain. Infarct size was determined by 
measuring areas of non-infarcted tissue in both the damaged and undamaged 
hemispheres. Infarct size was calculated as a ratio of ipsi/contra volume (7,8-DHF=0.932 
± 0.0144; Veh=0.864 ± 0.025). A Student’s t-test revealed a significant difference 
A
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between % tissue loss in 7,8- DHF group (DHF=8%) and the vehicle injected group 
(Veh=14%) p<0.03 (Figure 3.8).  
 
Figure 3.8 Volumetric analysis 
of the infarct size. 7,8-DHF 
treated rats had reduced tissue 
loss than vehicle treated rats.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.9 Lesion Representation. Representative coronal sections of 
7,8-DHF, Vehicle and Control rats stained with cresyl-violet and myelin.  
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3.3.5 Vasodilatory effects of 7,8-DHF 
To investigate the impact of 7,8-DHF on arterial endothelial cells of the cortex, 
rats were systemically given 7,8 DHF or Vehicle two hours prior to stroke induction. 
Baseline blood flow measures, using a laser Doppler, were recorded for a duration 10 
mins before ET-1 injection and recorded up to 90 mins post ET-1 application. There was 
>80% reduction in the cortical blood flow around MCA and its branches within 10 
minutes of stroke induction. The perfusion units were normalized to baseline measures. 
No significant differences were observed in the mean blood flow measures between 
vehicle injected and 7,8 DHF rats after stroke suggesting that the effects of 7,8 DHF were 
not due to increased vasodilation post ET-1 treatment (Figure 3.10).  
 
Figure 3.10 Blood flow measures post ET-1 using laser Doppler in 7,8-
DHF and vehicle injected rats. Images of the cortical surface at 
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various time points showing reduction in the blood flow in the region 
of ET-1 injection.  
3.3.6 7,8 DHF did not enhance p-TrkB expression in motor cortex  
To determine the ability of systemic 7,8-DHF to activate p-TrkB, in vivo, in 
healthy rats, TrkB and p-TrkB (at Tyr816) levels in the motor cortex and hippocampus 
were examined (Figure 3.11). Western blot analysis did not reveal a significant increase 
in the levels of p-TrkB in cortical homogenates compared to vehicle-administered rats. 
TrkB levels in neither 7,8-DHF nor vehicle receiving rats were changed. Over all, there 
was a higher expression of p-TrkB in the hippocampus, but no significant group 
differences were detected (Figure 3.12A,B).  
 
 
Figure 3.11 Representative bands generated after western blotting 
showing the density of pTrkB levels in 7,8-DHF and Vehicle treated rat 
brains in the motor cortex and hippocampus.  
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Figure 3.12 Western blot quantitative analysis.  Protein levels 
quantified and reported as a ratio of pTrkB/TrkB in motor cortex and 
hippocampal homogenates. No enhanced expression of TrkB 
phosphorylation was detected in 7,8-DHF rats compared to vehicle treated 
rats.  
 
3.4 Discussion 
The aim of this study was to investigate the efficacy of 7,8 DHF and determine its 
impact on motor recovery post cortical ischemia. A comprehensive behavioral testing 
paradigm was used, which proved to be effective in measuring impairment levels and 
detecting spontaneous behavioral improvements after injury.  
It was found that animals receiving 7,8 DHF prior to and after ischemia 
demonstrated milder impairments in their fine motor skills compared to vehicle treated 
animals. Data analysis revealed that in sunflower seed opening task, 7,8 DHF treated rats 
were significantly faster at consuming seeds than vehicle rats after stroke. During the 
vermicelli handling task, test measuring forepaw dysfunction, 7,8 DHF treated animals 
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did not differ from vehicle injected rats, nor were there any differences in forelimb 
asymmetries between the two groups in the cylinder task. Uluc and colleagues (2013) 
have shown that 7,8-DHF reduces white matter injury. Perhaps, it is due to his effect that 
the preservation of fine fractionated movements using digits was observed as opposed to 
improvement in gross motor performance. This pattern of functional recovery indicates 
that 7,8 DHF may be impacting the pyramidal neurons, which receive direct inputs from 
the sensorimotor cortex and are critical in driving upper extremity motor movements in 
the distal musculature requiring fine dexterity (Lemon, 1992). There is an enhanced 
expression of TrkB in dendrites of pyramidal neurons in layer V of neocortex in rats after 
ischemia (Narumiya, 1998). Therefore, these observation also suggests the importance of 
dendrites, as well as cell soma, for signal transduction of the TrkB receptors for its 
potential contribution to neurobehavioral outcome. 
In agreement with the behavioral findings, detailed forelimb motor maps 
generated from these animals showed that 7, 8 DHF treated animals had larger cortical 
forelimb representation than those of the vehicle injected animals, indicating a substantial 
amount of functional sparing in the flavone receiving group.  This is in part due to the 
smaller lesion size in the DHF animals. However, while the DHF animal’s lesions were 
half the size of the vehicle animals, the motor maps were several times larger suggesting 
that the differences in motor map area cannot be explained by lesion size alone. The 
enlargement of motor maps can be attributed to axonal sprouting due to upregulation of 
TrkB downstream signaling cascade influencing growth promoting genes (Carmichael, 
2005), hence facilitating the formation of new axonal projections.  
It is hypothesized that an ischemic insult causes a functional and anatomical 
52 
disruption of intracortical circuitry within peri-infarct regions of cortex. The disruption is 
manifested as a loss of movement representations and causes motor impairments. In 
support of this idea, regions of peri-infarct motor cortexthat exhibit a loss of movement 
representations alsoexhibit a reduction in synapse number (Kleim, 2001). The loss of 
motor map is thought to be the result of neuronal dysfunction and a disruption of cortical 
circuitry, as there is a loss of synapses but not neurons within these regions (Kleim 2003). 
Recent evidence from studies in mice suggests that following stroke there is a decrease in 
spine density by 38% in peri-infarct cortex at 24 hours  (Murphy et al., 2008). Previous 
experiments have demonstrated that in vitro 7,8-DHF rescues long-term synaptic 
plasticity in the hippocampus (Zeng et al. 2011). This finding may offer a plausible 
explanation for the better behavioral outcome and relatively bigger forelimb maps in the 
7,8-DHF group due to the strengthening of synapses and/or minimizing loss of synapses 
as a result of insufficient availability of BDNF to activate TrkB receptors, after an 
ischemic event.  
It is interesting to note that the proposed mechanism of 7,8-DHF functioning in 
the brain is via its binding to TrkB receptors, which then causes activation through 
phosphorylation of the protein (Jang et al. 2010). Surprisingly, administration of 7,8-DHF 
in healthy rats did not yield increased levels of TrkB phosphorylation in the sensorimotor 
cortex in comparison to vehicle receiving rats. It is noteworthy that the protein analysis 
was conducted in healthy and not ischemic animals where the differences may have been 
detected.  
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Vasodilatory mechanism of flavonoids 
In the experiments conducted by Jang and colleagues (2010), they showed that by 
injecting 7,8-DHF (5mg/kg) in rats 2 h prior to MCAO induction reduces infarct volume 
by 50% and apoptosis at 48 h. Previous studies have highlighted the effects of flavonoids 
in modulating endothelial function and dysfunction extensively. Endothelin-1 is a potent 
vasoconstrictor released by endothelial cells. Endothelial dysfunction is associated with 
elevation of endothelin-1 and in this model ET-1 was used to induce ischemia. 
Endothelium and nitrous oxide (NO) dependent relaxation has been reported for several 
isolated flavonoids, especially the anthocyanin delphinidin (Andriambeloson et al., 1998) 
and flavone chrysin (Duarte et al., 2001)of capillary endothelium(Tiurenkov, Voronkov, 
Slientsans, Petrova, & Dorkina, 2010). Certain flavonoids derived from cocoa extracts 
have also shown to have potent effects on endothelium relaxation (Karim, McCormick, & 
Kappagoda, 2000). It has been reported that 4 carbonyl group in flavones is required for 
the vasodilatory activity (Duarte et al., 1993). Duarte and colleagues were able to show 
that the main vasodilatory mechanism of flavonoids seems to be the inhibition of protein 
kinase C (PKC). An inhibitory effect on cyclic nucleotide PDE and Ca2+ uptake is also 
known to contribute to the vasodilatory action of flavones. Based on these findings, it 
was hypothesized that 7,8-DHF, due to its structural similarities to above mentioned 
compounds may cause vasodilation of the vessels. Blood flow changes were measured in 
anesthetized rats, treated with 7,8-DHF or vehicle 2 h prior to MCAO induction. There 
were no significant differences between the two groups. These findings lead to the 
conclusion that neuroprotective effects of 7,8-DHF do not appear to be due to changes in 
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vasodilation. Presumably 7,8-DHF is facilitating synaptic strengthening due to increased 
levels of TrkB in dendrites after ischemia.  
7,8-DHF acting through different signaling pathways 
Considerable evidence has accumulated to suggest that cellular effects of 
flavonoids may be mediated by their interactions with specific proteins central to 
intracellular signaling cascades, such as mitogen activated protein kinase (MAP kinase) 
signaling pathway and the phosphoinositide 3-kinase (P13K/Akt) signaling cascade. 
Treatment with quercetin after spinal cord injury has been correlated with recovery of 
motor function in a rat model (Schultke, Griebel, & Juurlink, 2010). Due to structural 
similarity it is believed that 7,8 DHF administration is potentially inducing motor 
recovery after ischemia by similar mechanisms.  
Neuroprotective effects of 7,8-DHF were evident through significantly reduced 
infarctions in 7,8 DHF treated animals compared to vehicle treated animals. For this 
compound to be considered neuroprotective, it is imperative that it effectively crosses the 
blood-brain barrier and provoke TrkB activation. Activation of the kinase receptor 
interferes with a large number of biochemical signaling pathways and, therefore, impacts 
physiological and pathological processes. One of the consequences of this activation is 
the stimulation of extracellular signal-regulated kinase (ERK) and protein kinase B (Akt) 
signaling cascade. Active ERK and Akt regulate the expression of specific genes that 
contribute to cell survival in an event of an injury (Almeida et al., 2005). However, it can 
only be speculated that these events took place in 7,8-DHF treated animals based on 
previous findings, since mass spectrometry was not conducted on this brain tissue to 
verify the penetration of the compound. Also, western analysis of downstream signaling 
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molecules was not performed to measure levels of downstream growth promoting 
proteins induced by TrkB receptor.  
It is important to note that 7,8-DHF is a poorly soluble compound and requires at 
least 30% DMSO4 to dissolve. Unfortunately, toxicity of DMSO4 as a solvent has been 
reported to be considerably high (Trivedi, 1990), consequently damaging a considerable 
number of neuronal population and repressing cell growth in the brain. Hence, this 
property of 7,8-DHF makes it less desirable of a compound to be administered after an 
ischemic injury.  
The improvement in motor function, even though not as robust as was predicted 
to be, is presumably by protecting vulnerable neurons or enhancing existing neuronal 
function by synapse strengthening (Zeng et al, 2011). Although specific pathways 
through which 7,8-DHF results in mediating neural plasticity still require further 
investigation, the results of these studies suggest that administration of 7,8 DHF after 
stroke supports partial functional recovery.  
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Chapter 4 
A novel TrkB agonist LM22A-4 enhances motor recovery and motor 
map plasticity following stroke 
4.1 Introduction  
Stroke remains the leading cause of adult disability in developed countries (AHA 
statistical update, 2012). Most survivors live with residual motor impairments that 
severely diminish independence and quality of life. After stroke, the only accepted 
treatment for these patients is motor rehabilitation. However, the amount and kind of 
rehabilitation required to induce clinically significant improvements in motor function is 
rarely given due to the constraints of our current health care system. In an effort to 
maximize recovery after stroke, another proposed method for improving rehabilitation is 
the combined use of drug therapy together with the physical therapy. Pharmacological 
intervention can alter plastic changes and the best documented evidence is with 
amphetamine and related noradrenergic agents (Feeney et al, 1993 & 1997), but these 
studies have produced some conflicting results. Therefore, developing adjuvant therapies 
that might augment the impact of motor rehabilitation, improve functional outcome and 
increase quality of life would be of great benefit.  
 Neurorehabilitation is used to promote relearning of original movements as well as 
learning compensatory movement patterns. Various studies in animals and humans have 
demonstrated reorganization of maps within motor cortex as a function of experience in 
both healthy and brain-injured animals/patients. Synaptic plasticity is the neural 
mechanism mediating motor learning and therefore motor relearning as evidenced by 
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restoration of movement representations within the spared cortical tissue accompanied by 
increase in synapse number translating into motor improvement after stroke (Wittenberg 
et al., 2003; Taub et al., 2003; MacDonald et al., 2007).Neurotrophic factors have been 
associated with physiological and anatomical plasticity to enhance motor recovery after 
stroke. Brain Derived Neurotrophic factor (BDNF) is one such neurotrophin and is 
known to modulate synaptic and morphological plasticity in the developing and mature 
nervous system (Lu et al., 2003; Reichardt et al., 2006). The most well characterized of 
these systems is the BDNF/TrkB receptor signaling pathway and have been implicated in 
neuronal survival, synaptic plasticity, and cortical reorganization after brain injury. 
 The beneficial role of BDNF in the brain makes it a viable therapeutic candidate. 
Unfortunately, BDNF itself is a poor candidate because of its short half life, low 
penetration through the blood brain barrier, and activating multiple receptor units, p75 
and TrkB on the neuronal membrane (Chao & Hempstead, 1995). Activation of the p75 
receptor can result in many undesired side effects such as pain (Zhang, Chi, & Nicol, 
2008) and apoptosis (Barrett et al. 2000).  
 A recently discovered compound, LM22A-4 (N,N’,N’-tris (2-hydroxyethyl)-1,3,5-
benzene tricarboxamide), is a small molecule ligand designed to mimic the loop II 
domain of BDNF (Massa, et al., 2010) has been shown to selectively mimic the cell 
signaling actions of BDNF on the TrkB receptor, actively cross the blood brain barrier, 
and enhances functional recovery in animal models of several neurological disorders 
(Han, et al., 2012; Schmid, et al., 2012). LM22A-4’s effects are qualitatively and 
quantitatively different than the native BDNF protein (Massa et al., 2010).  
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LM22A-4 compound interacts with and act through TrkB phosphorylation 
To verify that the compound works through activation of TrkB, the discoverers 
were able to block them by inhibiting receptor activation. Hippocampal neuron cultures 
were treated with Trk inhibitor K252a, which demonstrated a reduction in neurotrophic 
activity of the test compound and BDNF. As an alternative approach, the effects of an 
antibody directed against the extracellular domain (ECD) of TrkB that is known to inhibit 
BDNF function (Balkowiec et al., 2000) were examined. This resulted in a reduction in 
cell survival and increased numbers of TUNEL-positive cells in the presence of LM22A-
4 (Massa et al., 2010). Also, LM22A-4 specifically activated TrkB and this was verified 
by the addition of LM22A-4 to 3T3-TrkB and NGF cultures, which resulted in the 
activation of TrkB only. In another set of experiments LM22A-4 increased survival in 
3T3-TrkB cells by 56%, while no significant increase in survival was detected in 3T3-
TrkA, 3Te-trkC or 3T3-p75NTR cells.  
LM22A-4 can ameliorate behavioral impairments after TBI, Stroke and Rett’s 
syndrome  
Previous studies have demonstrated beneficial effects of LM22A-4 in other 
neurological disorders and injuries. LM22A-4 treated rats subjected to parietal controlled 
cortical impact injury showed increased rotarod performance, indistinguishable from 
sham-operated controls, 2-3 weeks after injury. Thus suggesting that LM22A-4 is able to 
reverse deficits in motor task learning caused by TBI. Schmid and colleagues developed 
respiratory dysfunction in heterozygous Mecp2 Het mice. LM22A-4 administration 
restored wild type breathing frequency in Mecp2 Het mice, therefore providing a 
validation of TrkB as a therapeutic target in mouse models of RTT (Schmid et al., 2012). 
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This study was designed to investigate the influence of LM22A-4 when combined 
with rehabilitative training in the form of single pellet reaching in facilitating motor 
recovery after stroke in a rat model. LM22A-4 in conjunction with motor rehabilitation, 
begun three days after middle cerebral artery occlusion significantly improved forepaw 
skilled reaching accompanied by an expansion of the secondary motor areas in severely 
injured rats.  
This study demonstrates that TrkB agonist treatment when paired with 
rehabilitation over an extended period of time is capable of improving functional 
recovery in severely injured rats. These results provide proof-of-concept evidence that 
activation of TrkB alone is a potential therapeutic approach for accelerating stroke 
recovery in patients who have suffered a stroke.  
4.2 Experiment 1: Validating The Efficacy Of LM22A-4 For Activating The TrkB 
Receptor 
In this experiment a dose of 5mg/kg i.p. LM22A-4 (N=5) and saline as Vehicle 
(N=5) was administered in healthy naïve Long Evans rats for seven consecutive days and 
in a separate experiment 25mg/kg i.p. of LM22A-4 (N=8) and Saline (N=7) was 
delivered in Long Evans rats from day 3-10 post stroke. Rats were sacrificed at 1 hour 
after the last dose of LM22A-4 or vehicle. Ipsilateral sensorimotor cortex was isolated, 
homogenized in cell lysis buffer, sonicated, and equalized as described in the methods. 
Protein extracts were subjected to Western blot analysis using standard techniques. Blots 
were probed with antibodies recognizing pTrkB-Y817 (rabbit mAb 1:30,000, Epitomics), 
TrkB (rabbit polyclonal antibody1:2500, Millipore), and HRP goat anti-rabbit (1:10,000, 
Pierce Biotechnology). Optical densities were measured using LiCor Odyssey Infrared 
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imaging system and Image J analysis. Ratios were calculated as pTrkB over full-length 
TrkB receptor and data was normalized to saline-treated stroked mice.  
4.2.1 LM22A-4 penetrates the brain after 7 day administration and phosphorylates 
the target receptor 
LM22A-4 did not increase p-TrkB levels in motor cortex in healthy rats  
To determine the ability of systemic LM22A-4 to activate p-TrkB in vivo in 
healthy naïve Long Evans rats were examined trkB and p-TrkB (at Tyr816) levels in the 
motor cortex. 5mg/kg (i.p) of LM22A-4 (N=5) or saline as Vehicle  (N=5) was 
administered for 7 consecutive days. Western blot results did not show a significant 
increase in the levels of pTrkB in animals receiving LM22A-4 compared to Vehicle 
treated group at this dosage. Mean pTrkB ratio of healthy LM22A-4 receiving rats was 
0.132 ± 0.016 and Vehicle receiving animals 0.136 ± 0.02 (Fig 4.1A). 
                                                                                         Figure 4.1 A) Western blot 
quantitative analysis (5mg/kg).  
pTrkB /TrkB ratio in the motor 
cortex after 7 days of LM22A-4 
(5mg/kg) in healthy rats. A low 
dose of LM22A-4 (5mg/kg) does 
not enhance TrkB phosphorylation 
in healthy rats. 
 
LM22A-4 enhances p-TrkB expression in motor cortex after stroke 
In this experiment 25mg/kg of LM22A-4 (N=7) and Saline (N=7) was 
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administered in Long Evans rats for seven consecutive days from days 3 to 10 after 
stroke. Rats were then sacrificed at 1 hour after the last dose of LM22A-4 or vehicle. 
Ipsilateral cortex was isolated and processed for western blotting analysis.  
LM22A-4 induced TrkB tyrosine phosphorylation in cortical neurons. There was 
a 27.7% (p < 0.03) increase in the levels of pTrkB in LM22A treated rats when 
normalized to total TrkB (Fig 4.1B).  
 
 
 
 
 
 
 
 
Figure 4.1 B) Western blot quantitative analysis (25mg/kg).   
pTrkB /TrkB ratio in the motor cortex after 7 day administration (i.p.) of 
LM22A-4 (25mg/kg) and saline in stroke rats. LM22A provokes TrkB 
phosphorylation at a higher dose (25mg/kg) in stroke rats compared to 
vehicle treated stroke rats (p < .03). 
 
LM22A-4 crosses the blood-brain barrier  
The brain concentration of LM22A-4 was evaluated in rats treated daily with 
25mg/kg i.p. from days 3-10 after stroke, then sacrificed at 1 hour after the last dose of 
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LM22A-4 or vehicle. Ipsilateral hemispheres were obtained and immediately frozen on 
dry ice. The tissue extraction and LC-MS/MS analysis were performed by Absorption 
Systems (Exton, PA). Brain homogenate from an untreated Long Evans rat was used for 
the standard curve. 
 A concentration of 53.98 ± 17.01 nM of LM22A-4 in brain tissue of drug 
administered rats was reported. The concentration in plasma was much higher 7291.82 ± 
4209.93 nM. Atenolol, a drug that does not cross the blood-brain barrier, was 
administered with the last dose of LM22A-4 as a control to correct for contamination by 
blood present in the brain vascular space.  
 
4.3 Experiment 2: Motor Rehabilitation and drug treatment  
Using the results from experiment 1 showing that 25mg/kg of LM22-A was 
effective for increasing pTrkB, the efficacy of a novel TrkB agonist (LM22A-4) was 
investigated for reducing behavioral and neurophysiological impairments associated with 
cortical ischemia in rats. Animals were tested on a comprehensive battery of motor tasks 
before and after stroke and treated with LM22A (25mg/kg; i.p.) or saline along with 
receiving motor rehabilitation in the form of skilled reaching movement. Intracortical 
microstimulation (ICMS) was used to assess neurophysiological correlates of enhanced 
motor performance within the motor cortex. Histological analysis was performed to 
verify the extent and size of the lesion.  
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Figure. 4.2 Schematic drawing of the experimental design 
 
Forty Long Evans hooded male rats were used in this experiment. Immediately 
following handling, all animals completed a comprehensive behavioral testing battery to 
assess forelimb motor function from gross motor movements to performing fine object 
manipulations. These tasks included: single pellet reaching, cylinder forepaw placement 
testing, vermicelli pasta handling and sunflower seed opening across approximately two 
weeks.  
Single Pellet Reaching Task  
The single pellet-retrieval test (McKenna & Whishaw, 1999; Miklyaeva & 
Whishaw, 1996; Peterson & Devine, 1963; Withers & Greenough, 1989) was performed 
in a Plexiglas chamber with a tall narrow window in the center of the front wall. Animals 
were placed on scheduled feeding (13-17g rat chow/one time per day) beginning two 
days before experiments began to motivate reaching behavior. All animals were given 
banana flavored food pellets (45 mg, Bioserve, Inc.) in their home cages for 
approximately two weeks before the start of reaching behavior to reduce neophobic 
responses to unknown food. Animals were shaped over several days on the tray reaching 
multiple pellets reaching task whereby a limb of preference (dominant limb for the task) 
was established (more than 15 reach attempts with same limb over a 20 minute period). 
After a dominant limb was established, animals were trained on the single pellet 
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retrieval task to a proficient level (> 40% success/reach attempt) with this forelimb. Pre-
operative training consisted of 15 min sessions in which, on each trial, rats could make up 
to 5 reach attempts for a banana pellet located in a shallow well (1 cm from the window). 
A trial ended when greater than 5 reach attempts (extension of the forepaw through the 
window) were made or the pellet was knocked from its well (failures), the pellet was 
dropped inside the chamber before consumption (drop), or when the pellet was 
successfully retrieved from its well and eaten. A short pause preceded each trial such that 
the animal was distracted from, or turned away from, the center window (by tapping on 
the side of the chamber, or by dropping a pellet in the chamber) while a new pellet was 
placed in the well.  
This task is exceptionally sensitive to cortical damage given the level of difficulty 
required to perform successful reaches. The impairment level of each animal was 
calculated by (Post stroke accuracy/Baseline accuracy) X100. 
Following collection of baseline data, animals were randomized to either 1. 
Control; 2. Stroke+LM; 3. Stroke+Veh. The assignment before inducing ischemia was 
done in a manner that counterbalanced reaching baseline performance such that all 
groups had equivalent mean baseline reaching accuracies. Animals then received a focal 
cortical infarct via topical application of endothelin 1 onto forelimb motor cortex and 
were allowed to recover for four days before they were again tested on the same battery 
of motor tests (approximately one week). Animals were placed into additional conditions 
for analysis based on the level of impairment shown on the single pellet reaching task. 
The impairment level of each animal was calculated by (Post stroke accuracy/Baseline 
accuracy) X100. Stroke animals performing at 20% or less of baseline levels were 
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considered severely impaired while animals performing above 25% of baseline levels 
were considered mildly impaired. This resulted in five groups of animals 1. Healthy 
Control (N=12); 2. Mild Stroke+LM (N=5); 3. Severe Stroke+LM (N=5); 4. Mild 
Stroke+Veh (N=5); 5. Severe Stroke+Vehicle (N=5). Animals were placed into 
additional conditions for analysis based on the level of impairment shown on the single 
pellet reaching task (Table 4.1).  
Stroke animals performing at 20% or less of baseline levels were considered 
severely impaired while animals performing above25% of baseline levels were 
considered mildly impaired. This resulted in five groups of animals.  
 
Table 4.1 Stratification of rats based on impairment levels after stroke 
 
Condition # Animals % Baseline (Reach Accuracy) 
Control 9 110.8% 
Veh-Mild 5 59.8% 
Veh-Severe 5 5.5% 
LM-Mild 5 52.9% 
LM-Severe 5 9.1% 
  
 LM22A-4 treatment (25mg/kg i.p.) and motor rehabilitation was initiated 3 days 
after stroke and continued for approximately seven weeks. The drug was not 
administered during week six, the administration was reinstated during week seven. 
Periodic testing on the motor test battery was performed to assess both impairment and 
recovery profiles. ICMS was then used to derive topographical maps of the forelimb 
representations in both the lesioned and intact hemispheres. 40m tissue sections were 
then taken through the frontal cortex and stained for nissl substance and myelin to assess 
lesion volume (Figure 4.2).  
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4.3.1 Differential Effects of LM22A-4 on Severely vs Mildly impaired rats  
A repeated measures ANOVA with CONDITION as a between subject factor  
and TIME as a within subjects factor revealed a significant CONDITION X TIME 
interaction on mean reaching accuracy [F(180,810)=1.54; p<0.001]. Subsequent  
multiple comparisons (Fisher’s PLSD; p<0.05) revealed that all animals in all four  
stroke conditions exhibited significant reductions in reaching accuracies in comparison to 
Controls. 
LM-Mild and Veh-Mild conditions showed transient impairments that lasted for 
the first four days of motor rehabilitation after which they performed at control levels. 
They showed a progressive increase during the Off-Drug phase that continued on after 
drug treatment was resumed to the point where they were performing at level 
significantly higher than controls on the last few days of training (Days: 36-45). A 
different pattern of results was observed in the severely impaired animals. Both the LM-
Severe and Veh-Severe animals showed profound decreases in reaching accuracy after 
insult. However, animals in the LM-Severe condition showed a gradual increase in 
reaching accuracy and were performing at significantly higher levels than Veh-Severe 
animals by the third week of rehabilitation. During the Off-Drug phase they showed an 
initial decrement in performance that was followed by a progressive increase in reaching 
accuracy back to and on two days out performed the Controls (Figure 4.3). 
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Figure 4.3 Single-pellet retrieval after stroke. 
 
Single pellet reaching performance in severely and mildly impaired rats. 
Depicts daily data of all five groups during rehabilitation training period.  
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4.3.2 Enhanced Reaching performance observed during ‘off drug’ phase post stroke 
 An interesting pattern was observed in the behavior during one week off drug phase 
after 5 weeks of continuous daily administration. Initially there was a drop in the 
performance on skilled reaching task, but after 3 days there was a sudden upward spike in 
their performance accuracy (Figure 4.3).  
 
4.3.3 Sunflower Seed Opening Test 
To measure fine digit manipulation, animals were tested every two weeks for the 
first six weeks of training on sunflower seed opening task. The average time to consume 
5 seeds in intact animals is approximately 45 seconds. A repeated measures ANOVA 
with CONDITION as a between subject factor and TIME as a within subjects factor 
revealed a significant CONDITION X TIME interaction on mean reaching accuracy 
[F(3,29)=3.14; p<0.01]. In comparison to Baseline performance, all animals in the stroke 
conditions showed a significant increase in time to open the seeds two weeks post stroke. 
Initially, LM-severe group showed the most impairment by taking the longest time to 
complete the task (66.67 ± 11.39s) after two weeks post stroke. All animals showed 
significant improvement in the task (LM-Severe = 41 ± 2.16s) on week four and six, 
except for the Veh-Severe animals which failed to show any significant recovery (Figure 
4.4).  
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Figure 4.4 Time to consume 5 seeds on sunflower seed opening task 
LM22A-4 rats start showing reduced times in consuming sunflower seeds 
after 4 weeks of drug administration compared to vehicle treated rats.  
 
4.3.4 Pasta Handling behavior 
Time to eat. A repeated measures ANOVA with CONDITION as a between 
subject factor and TIME as a within subjects factor revealed a significant CONDITION 
X TIME interaction on mean reaching accuracy [F(3,29)=3.74; p<0.01].All rats took 
significantly longer to consume the pasta pieces after stroke. There were no significant 
differences between LM receiving and vehicle treated animals post injury, except that 
rats with severe stroke took longer than mildly impaired rats to eat the pasta pieces at 
week 2, 4 and 6. Further, LM-Mild took significantly less amount of time than Vehicle 
receiving rats when compared to their baseline measures. Difference between pre and 
post injury times for Veh-Mild=-37.22%; LM-Mild=-9.8%; Veh-Sev=-97%; LM-Sev=-
83.2%; Control=-49.67%.  
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4.3.5 LM22A-4 induces expansion of rostral forelimb area  
Ipsilesional Maps: A one-way ANOVA with CONDITION as a between subject 
factor was conducted on cortical surface area occupied by the total forelimb area, CFA 
and RFA. Results showed a significant main effect of CONDITION on total forelimb 
area [F(4,24)=10.79; p<0.001], CFA [F(4,24)=11.32; p<0.001], and RFA [F(4,24)=3.72; 
p<0.01]. Subsequent multiple comparisons (Fisher’s PLSD; p<0.05) revealed that all 
animals in the stroke conditions had significantly smaller forelimb motor maps in 
comparison to controls (LM-Mild=3.58 ±  0.5 mm2, LM-Severe=3.05 ± 0.2mm2, Veh-
Mild= 3.7 ± 0.4 mm2, Control=5.2 ± 0.3 mm2). Further, Veh-Severe animals had 
significantly smaller maps than all other conditions (Veh-Severe=0.8 ± 0.2 mm2). This 
same pattern of results was observed for measures of CFA with animals in the LM-
Severe group (LM-Severe=1.9 ± 0.3 mm2) having smaller total CFA areas than both the 
LM-Mild (2.8 ± 0.4mm2) and Veh-Mild (3.2 ± 0.3 mm2). Finally, the Veh-Severe 
animals again had significantly smaller mean CFA area than all of the conditions (0.7 ± 
mm
2). Interestingly, the RFA showed a different pattern of results. The RFA of LM-
Severe animals was significantly larger than all other conditions including the controls 
(LM-Severe=1.15 ± 0.08 mm2, LM-Mild=0.65 ± 0.1 mm2, Veh-Mild= 0.5 ± 0.1 mm2, 
Control=0.6 ± 0.13 mm2) Conversely, the Veh-Severe animals had significantly smaller 
maps than all other conditions (Veh-Severe= 0.02 mm2) (Figure 4.5).  
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Figure 4.5 Forelimb motor map area (ipsilesional). Forelimb motor 
map area (ipsilesional) in control, LM22A and vehicle receiving rats. 
Caudal and rostral forelimb maps are severely reduced in Veh-severe rats, 
LM-severe rats have the largest rostral forelimb area compared to all other 
groups, including controls.  
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Figure 4.6 Representative forelimb motor maps (Ipsilesional) 
Motor maps from a control, LM-Mild, LM-Severe, Veh-Mild and Veh-
Severe rat showing caudal and rostral forelimb areas consisting of distal 
(wrist/digit) and proximal (elbow/shoulder) representations on the sensory 
motor cortex. Increased representation of wrist and digits is seen in rostral 
forelimb area in LM-Severe rats.  
Contralesional Maps. Contralesion map analysis revealed Veh-mild having the largest 
(Veh-mild= 6.75 ± 0.99 mm2) and LM-Severe having the smallest total forelimb area 
amongst all groups (LM-Severe= 3.4 ± 0.99 mm2). Control rats had an average area of 
3.7 ± 0.7 mm2, Veh-severe= 4.5 ± 0.99 mm2 and LM-mild = 4.87± 0.99 mm2 (Fig 4.7). 
There were no significant differences between any of the groups.  
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 Figure 4.7 Total forelimb area in contralesional hemisphere. Forelimb 
motor map (contralesional) area in control, LM22A-4 and vehicle 
receiving animals.  
 
4.3.6 Infarct Size 
To assess potential neuroprotective effecs of LM22A on infarct size, the volume 
of the remaining non-infarcted tissue was measured. The ischemic infarct typically 
included lateral regions of cortex. (Fig 4.8) Represents the topographic location of the 
ischemic infarct in vehicle receiving severely impaired rat. Infarct size was determined 
by measuring areas of non-infarcted tissue in both the damaged and undamaged 
hemispheres by using Image J software. These area measures were then used to calculate 
values corresponding to the volume of remaining hemispheric, cortical and subcortical 
tissue. Data is represented as ratio of mean volumetric values of ipsilateral over 
contralateral hemisphere in Fig 4.10. Severely impaired vehicle receiving rats has 
significantly larger infarcts than all other stroke animals. Ratio measured in Veh-
Sev=0.77 ± 0.07 and Veh-Mild=0.99 ±0.01) (p < .05). Lesion size of LM-Severe animals 
was not significantly different from LM-Mild rats (LM-Sev=0.90 ±0.03; LM-Mild=0.934 
± 0.02) 
Analysis revealed that all four stroke groups had significantly reduced spared 
tissue than the controls, but no significant difference in infarct size was found between 
Veh-mild and LM-mild animals. Veh-severe animals had significantly reduced volume 
than all other conditions.  Volumetric analysis shows that LM22A-4 may have 
contributed towards tissue sparing in severely stroke animals by inducing its 
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neuroprotective effects as both LM-mild and LM-severe animals have no significant 
differences in lesion size (Figure 4.9).  
 
Figure 4.8 Coronal sections of representative ischemic infarct in Veh-
severe rat. 
 
            
Figure 4.9 Volumetric analysis of lesion size. Data is represented as ratio 
of mean volumetric values of ipsilateral over contralateral hemisphere.  
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4.4 Discussion 
The goal of this study was to test the viability of LM22A-4 on motor recovery in a 
clinically relevant model. Cortical ischemia was induced by injecting a vasoactive 
peptide Endothelin-1, which causes a temporary occlusion of the branches of the middle 
cerebral artery supplying blood to the sensorimotor cortex. The damage caused by this 
method results in a significant neurological injury similar to that seen in disabling of 
upper extremity in human stroke. Stroke animals demonstrated substantial motor deficits 
allowing behavioral testing to be performed to measure the impairment and recovery 
profiles across multiple time point. Further, the drug was administered systemically 
rather than directly into the brain to mimic how it could be used clinically. Finally, 
changes in motor map area were measured to allow for potential translation to clinical 
studies using transcranial magnetic stimulation to monitor motor cortex plasticity. The 
key findings of this study are that stimulation of TrkB signaling with a small molecule 
partial agonist can improve functional recovery and enhance motor map plasticity in 
animals with severe but not mild motor impairments.  
LM22A-4 Is Not Neuroprotective 
In this study, the rats were trained prior to stroke to evaluate functional recovery 
rather than learning, and LM22A-4 administration was initiated three days after stroke to 
minimize any potential neuroprotective effects. No significant differences in lesion size 
between vehicle and LM22A-4 treated animals were observed suggesting that the 
observed differences in motor performance and motor map topography were not due to 
the sparing of neural tissue.  
It is speculated that the dose of 5mg/kg is insufficient to activate TrkB receptors 
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significantly in a healthy brain. Absorption of material delivered intraperitoneally is 
typically much slower than for intravenous injection, because the primary route of 
absorption is into the mesenteric vessels, which drain into the portal vein and pass 
through the liver (Lukas G., Greengard P., 1971). Therefore a higher dose may have 
greater chances of passing the blood brain barrier. Also, it has been reported that after an 
ischemic injury, there is an increased availability of TrkB receptors in the peri-infarct 
region (Gordon et al, 2009), a higher dose of 25mg/kg was effective in penetrating 
through the brain and enhance p-TrkB levels when administered after stroke.  
 
LM22A-4 Differentially Affected Severe vs. Mildly Impaired Animals 
LM22A-4 produced dramatic effects on motor recovery after an extended period 
of rehabilitation training in the form of single pellet reaching task. LM-Mild and Veh-
Mild conditions showed transient impairments that lasted for the first four days of motor 
rehabilitation after which their scores returned to the normal range. LM-Mild continued 
showing a progressive increase in their scores and eventually out performed the controls 
and Veh-mild rats, which was sustained till the end of the training period.  
Similarly, rats demonstrating severe impairments after injury when treated with 
LM22A started showing a progressive increase in their reaching performance compared 
to vehicle receiving severely impaired rats, which failed to show any improvements in 
single pellet reaching.  However, most marked behavioral improvements in LM-severe 
group were seen from week 3 onwards (after 22 days of consecutive i.p. administration). 
These results indicate that LM22A-4 treatment is effective when administered for an 
extended period of time, where it’s able to penetrate into the brain and augment  
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pro-recovery mechanisms presumably by inducing axonal sprouting, increased dendritic 
density and strengthen synapse formation. This pattern of recovery highlights a critical 
aspect of rehabilitation training that improvements can take weeks, which is a novel 
finding because most animal models show mild impairments that are restored quickly. 
This is encouraging when thinking of translating it to the clinic. It can be assumed that 
extensive behavioral training may have had a pro-neurogenic effect. However, since 
control and vehicle treated rats received identical training, the observed increase in 
neurogenesis occurred on top of this background. It has been established in previous 
studies that LM22A-4 increases neurogenesis in the absence of stroke and training (Han 
et al, 2012). 
It is important to point out that while viewing the recorded sessions in slow 
motion, LM-Sev animals displayed several sensory errors while retrieving the pellet. 
Some rats would hold the pellet for a brief period of time before consuming it, which 
implies that these rats were relying on cutaneous sensory feedback for successful 
completion of the trial. Also, over all there were fewer trials per each session. 
 
LM22A-4 Induces An Expansion Of RFA 
In correlation with motor performance, neurophysiological evidence revealed that 
LM22A-4 mediates cortical plasticity by facilitating recovery through expansion of the 
secondary motor areas. In many animals, including non-human primates rostral and 
caudal forelimb motor cortex contain different proportions of digit, wrist/forearm, and 
proximal representational area (Nudo et al., 2003).  The target lesion was the primary 
sensorymotor cortex. Motor maps of mildly impaired rats remained unchanged, and this 
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is because mild deficits may only require minor post-lesion learning (or compensatory 
motor strategies) for which the intact, adjacent neuronal network would be sufficient. 
LM-severe rats showed a relative preservation of reaching due to expansion of secondary 
motor. A plausible explanation offered for this is that after a cortical lesion, cortical areas 
distant from the site of injury are known to undergo physiological and anatomical 
changes. Motor learning has been found to be essential for the expansion of cortical 
motor representations (Plautz et al., 2000). However, the mechanisms through which 
reorganization of distant cortical areas is initiated are poorly understood. 
This data underlines the complex interactions between various components of the 
cortical motor system. Compensatory changes that occur in regions distant from the site 
of an injury are not exclusively based on rules of cortical connectivity. The ability for 
motor maps to reorganize is related to strengthening of synaptic connections, which is 
experience dependent (Kleim et al., 2002). The reorganization of peri-lesion cortex after 
stroke, including reorganization of motor maps, has been linked with functional recovery 
(Nudo, 2003). Furthermore, direct demonstration of axonal sprouting in the peri-infarct 
cortex following focal stroke has been shown by Carmichael and colleagues 
(Carmichael., 2001). 
Nudo and colleagues (2003) have shown that increase in the PMV hand 
representational area was directly proportional to the relative size of the primary motor 
cortex infarct. It appears that reorganization of the secondary cortical areas is a general 
feature of injury-induced plasticity. Another proposed theory is that remote 
reorganization is directly related to the reciprocal connectivity of the various motor areas. 
The greater the damage to reciprocal intracortical pathways, the greater the plasticity in 
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the secondary intact area (Nudo, 2006). Evidence for the contribution of premotor cortex 
to recovery has come from both human (Fridman et al. 2002; Miyai et al. 1999) and 
animal (Castro-Alamancos and Borrel 1995; Liu and Rouiller 1999) studies. Results from 
a transcranial magnetic stimulation study suggest that premotor cortex contributes to 
functional motor recovery in human stroke patients (Fridman et al., 2002). Miyai et al. 
(1999) reported that following middle cerebral artery occlusion, recovery in human stroke 
survivors was improved in those with intact premotor cortex compared with those that 
had premotor cortex damage. Hence it’s feasible to assume that in LM22A-4 treated 
severe animals, non-primary motor areas contribute to functional recovery following 
injury in primary motor cortex.  
This study provides an understanding of modulatory effect of combined 
behavioral and pharmacological interventions on neurophysiologic reorganization. The 
plastic changes observed here have been magnified in RFA with appropriate 
physiotherapeutic and/or pharmacotherapeuric intervention. Further study of sprouting 
patterns and synaptic structure and function in stroke models that can be identified and 
quantified (Carmichael et al., 2010; Carmichael et al., 2011) will be needed to 
conclusively determine if LM22A-4 has an effect on post-stroke plasticity.  
 
Stopping Drug Treatment May Enhance Motor Improvement 
The initial decrement and then increase in performance of LM-severe animals 
during “Off Drug” phase is intriguing. Multiple studies have indicated that for optimal 
BDNF/TrkB signaling events, the physiological range must be maintained (Lu and 
Gottschalk, 2000; King 2001). It is possible that daily administration of the drug prior to 
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suspension may have saturated the available TrkB receptors with functional catalytic 
domain, which led to aninitial decline in their motor skills. An enhancement in 
performance during “off drug” week suggests that continued administration of the drug 
could set up an ongoing increment in synaptic function due to the elevation of 
transcription factors induced by neurotrophin agonist binding that might last days or 
weeks.  
The subsequent improvement in their reaching abilities suggests the possibility  
TrkB receptor signaling cascade in setting up an ongoing increment in synaptic function 
off drug that might last for days or weeks. Hence, intermittent treatment of the drug may 
be considered when translating into a clinical setting.  
 
Potential Mechanism 
Two types of cellular events have been implicated in functional recovery after 
stroke, neurogenesis and neuronal plasticity. BDNF may promote both by binding its two 
receptors, TrkB and p75NTR. These expereiments tested whether LM22A-4, as a small 
molecule ligand selective for the TrkB receptor, would be able to induce these effects. 
Neurogenesis occurs in the weeks and months after stroke and may augment damaged 
neuronal networks (Ohab and Carmichael, 2006; Lichtenwalner et al, 2006; Jiang et al, 
2007). BDNF may increase neurogenesis by increasing survival of new neurons (Bath & 
Lee, 2010; Goldman et al, 2001; Chen et al, 2008) perhaps by strengthening new 
synapses. Plasticity likely contributes to functional recovery via rewiring of neuronal 
circuits, as reviewed recently (Carmichael, 2010; Benowitz. 2010; Murphy & Corbett, 
2009). BDNF and TrkB are critical for activity-dependent plasticity and LTP (Mattson et 
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al, 2004; Cunha et al, 2010).  A selective TrkB ligand such as LM22A-4, which does not 
activate p75NTR, may be more beneficial after stroke than BDNF. 
It is proposed that improvements on skilled reaching and sunflower seed opening 
tasks may be mediated at least in part via an effect on the synaptogenesis of layer V 
pyramidal neurons of sensorimotor cortex, which coordinate forepaw reaching and fine 
digit manipulation and are sensitive to the neurotrophic effects of BDNF. BDNF is 
normally delivered to these neurons via inputs from primary motor cortex (Hiebert GW, 
2002), which is injured in this stroke model and pharmacological TrkB activation may 
compensate for this loss. Increases in TrkB phosphorylation in cortical homogenates after 
7 days of LM22A-4 treatment are consistent with this hypothesis. This suggests that 
LM22A-4 will facilitate recovery from stroke, and may improve motor function in 
patients after potentially disabling strokes. 
It is clear from both preclinical and clinical studies that post-injury training is an 
important element in promoting recovery. The quality of the post-injury experience is 
crucial to the rate and extent of recovery. LM22A-4 specifically binds and activates the 
BDNF receptor TrkB, and results from this study indicate that this alone is sufficient to 
promote recovery. These findings show that LM22A-4 when paired with behavioral 
experience appears to facilitate recovery in an additive or interactive way. 
Neuromodulation of plasticity is helpful to enhance plasticity, creating a permissive state 
for learning. LM22A-4 may enhance neural signals to maximize sensorimotor 
integration. Despite these promising findings many factors related to the optimal design 
of clinical trials pairing LM22A-4 and behavioral experience, such as timing of treatment 
relative to injury onset, and the timing, quality and quantity of the behavioral experience 
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have yet to be established. This particular study design in an animal model outlines the 
importance of active ingredients such as repetitive and progressive training paradigms 
that will yield better functional motor outcome after stroke.  
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Chapter 5 
Middle cerebral artery occlusion induces limb motor deficits and 
reduces forelimb motor maps, but does not affect cranial motor function 
or oral motor maps 
5.1 Introduction 
 Among stroke subtypes, ischemic etiology is the most frequent cause of stroke, 
survivors of acute stroke often experience oral motor impairments, such as dysphagia, 
dysarthria and apnea that significantly reduces the quality of life in stroke patients 
(Martin & Corlew, 1990; Trapl, Eckhardt, Bosak, & Brainin, 2004). Despite a wealth of 
clinical and preclinical research investigating novel treatments to enhance recovery of 
upper and lower extremity impairments, the treatment of dysphagia has received 
comparatively little attention. There are no currently no animal models of post stroke 
dysphagia. The current study attempted to create an animal model of post stroke oral 
motor impairment. 
Respiratory disorders and swallowing dysfunction after stroke 
Dysphagia is a symptom of difficulty in swallowing. Normal swallowing involves a 
complex sequence of carefully timed muscular contractions that transport food from the 
mouth to the stomach whilst ensuring protection of the airway. The central regulation of 
swallowing depends on swallowing centres in the brainstem, which receive sensory input 
from pharynx and oesophagus and, together with local peristaltic mechanisms, control 
much of the swallowing sequence (Miller, 1982; Jean, 1990). However, the initiation of 
swallowing is a voluntary action that requires the integrity of motor areas of the cerebral 
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cortex. If these higher centers, or their connections to the brainstem, are damaged, then 
patients have severe difficulty in starting a swallow without choking (dysphagia) (Horner, 
1988; Alberts, 1992). Dysphagia is often accompanied with dysarthria, which is a motor 
speech disorder resulting from neurological injury of the motor component of the motor-
speech system (Joseph D, 2005), which can eventually lead to abnormal patterns. Apnea 
is referred to suspension of external breathing. Under normal breathing conditions gas 
exchange primarily controls the rate of respiration. During apnea there is no movement of 
the muscles of respiration and the volume of the lungs initially remains unchanged. 
Depending on the patency of the airways there may or may not be a flow of gas between 
the lungs and the environment (Cohen, 1959).  
Second to hemiparesis, these impairments are the most frequent neurological deficits 
in patients with first-ever acute ischemic stroke (Lubart et al., 2005). The incidence of 
dysphagia after stroke approximates 55% in the acute stage (Guyomardet al., 2009; 
Martino et al., 2005), while the incidence of dysarthria ranges between 25% (Lubart et 
al., 2005) and 42% (Lawrence et al., 2001). Many studies have reported the co-
occurrence of these impairments after stroke. Lapointe and McFarland (2004) 
documented that 79% of their acute stroke patients with dysphagia had concomitant 
communication impairments, such as dysarthria, aphasia, and respiratory impairments. 
Trapl et al. (2004) reported that 10% of their acute stroke patients had both dysarthria and 
aphasia. Currently, there are no known clinical predictors of these co-occurring 
impairments after acute stroke.  
These impairments have been associated with significant reductions in patient quality 
of life, social interactions and mental well-being. Dysphagia can lead to malnutrition 
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(Crary et al., 2013), dehydration (Crary et al., 2013), aspiration pneumonia (Martino et 
al., 2005) and death (Altman,Yu, & Schaefer, 2010). Given these potentially detrimental 
outcomes, it is important to identify precursors of dysphagia and respiratory dysfunction 
after stroke and understand the underlying neural mechanisms leading to malfunctioning 
of these systems. These efforts will aid in developing measures to assess clinical practice 
behaviors and reduce oral motor complications in stroke patients.  
Cortical reorganization of swallowing musculature after stroke 
In an effort to develop neurobiologically informed therapies that can enhance oral 
motor function in clinical population affected by stroke, it’s essential to identify the 
neuroanatomical substrates that facilitate the coordination of various muscles associated 
with these functions. Considerable evidence has accumulated to establish that lateral 
precentral cortex contains the motor representations for the tongue and face (Sessle et al., 
1997; Murray et al, 1992). It is believed that cortical bulbar pathways receives inputs 
from cortical motor regions, including supplementary motor, primary motor, and the 
subcortical motor connections, which are more commonly involved with muscle 
coordination during swallowing than posterior cortical regions (Daniels, 1999). Given 
that bilateral sensorimotor systems facilitate normal swallowing behaviors (Conklin et al, 
1997), consequently allowing great potential for recovery after damage: the majority of 
stroke patients recover within weeks of the insult (Barer, 1989). Interestingly though, 
mapping these projections have demonstrated that various swallowing muscles are 
arranged somatotopically, with the oral muscles, laterally and that in the majority of 
individuals, the projection from one hemisphere tends to be larger than the other. This 
reveals that there is an asymmetric representation for swallowing between the two 
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hemispheres, independent of handedness (Hamdy, 1998). This fact about the organization 
of cortical control of swallowing in humans highlights aspects of its reorganization, 
which are important for compensation and recovery after damage. Hence, swallowing 
could turn out to be an excellent model for studying central nervous plasticity.  
Hamdy and colleagues have shown that damage to the hemisphere that has the greater 
swallowing output appears to predispose that individual to swallowing problems, while 
damage to the hemisphere with the smaller swallowing output will not affect swallowing 
(Hamdy, 1997). However, when there is dysphagia because there is additional substrate 
for swallowing in the undamaged hemisphere, the capacity for compensatory 
reorganization in the contralateral motor cortex can be increased, leading to a greater 
likelihood of recovery. Thus it would be desirable to devise techniques that might be 
useful in speeding up the process of recovery.  
Breathing control centers in the brain 
Ventilation is normally controlled by the autonomic nervous system with only limited 
voluntary override. The pattern of motor stimuli during breathing can be divided into 
inspiratory and expiratory phases. Inspiration shows a sudden, ramped increase in motor 
discharge to the inspiratory muscles (including pharyngeal dilator muscles). Before the 
end of inspiration, there is a decline in motor discharge. Exhalation is usually silent, 
except at high minute ventilation rates (Thibodeau et al, 2009). The mechanism of 
generation of the ventilatory pattern is not completely understood, but involves the 
integration of neural signals by respiratory control centers in the medulla and pons. 
Ventilation is achieved through combinations of tidal volume and breathing frequency 
and is an integrated homeostatic response designed to help maintain cellular metabolism 
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and acid base balance in the face of environment and metabolic changes in CO2 and O2 
levels (Raven et al., 2007).  
Swallowing and aspiration pneumonia are highly coordinated and integrated systems. 
Cranial nerves that control the muscles involved in planning and programming aspect of 
the motor-speech system include trigeminal nerve's motor branch, the facial nerve, 
the glossopharyngeal nerve, the vagus nerve, and the hypoglossal nerve. Dysphagia, 
dysarthria and malfunctioning in normal breathing control are common sequelae of both 
cortical and subcortical stroke. Individuals suffering from dysarthria also experience 
challenges in various speech sub systems and diaphragm dysfunction is one of them 
(MacKenzie, 2011). Some preliminary evidence exists that cortical pathways (voluntary) 
contribute to the control of breathing during states of respiratory challenge/stress 
(Davenport, 2009). 
Despite a number of animal models for examining the neural substrates of general 
motor symptoms of stroke, there is a paucity of models for investigating neural 
mechanisms underlying cranial motor impairments. This study was designed to establish 
a rodent model of oral motor and respiratory dysfunction after stroke.  
Specifically for this purpose a comprehensive battery of motor tasks was 
employed that dissociates cranial motor and upper extremity impairments after unilateral 
cortical ischemia. Further, intracortical microstimulation (ICMS) technique was used to 
generate detailed motor maps of cranial motor and upper extremity movement 
representations within motor cortex. The underlying hypothesis was that middle cerebral 
artery occlusion disrupts corticospinal tract and corticobulbar projections from the motor 
cortex. ICMS provides a method for measuring the integrity of corticospinal (upper 
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extremity) and corticobulbar (cranial motor) circuits after middle cerebral artery 
occlusion. 
5.2 Methods 
Adult male Long Evans rats were used in this study.  Nine were healthy controls 
and five animals received a unilateral middle cerebral artery occlusion (MCAO).  All rats 
were trained on a variety of behavioral tasks used to determine baseline measures for 
forelimb and oral motor tasks.  Forelimb tasks included the single pellet reaching task 
(Whishaw et al., 1992), cylinder paw placement task (Schallert et al, 2000), sunflower 
seed opening task (Kleim et al., 2007), and the pasta handling task (K. A. Tennant et al., 
2010).  Subjects were trained for single pellet reaching for twenty-one days, and the 
remaining motor tasks for three days each before induction of ischemia (Figure 5.1).  
 
Figure 5.1 Schematic drawing of the experimental design  
Forelimb Motor Testing 
Single pellet reaching task. The single pellet-retrieval test (McKenna & Whishaw, 
1999; Miklyaeva & Whishaw, 1996; Peterson & Devine, 1963; Withers & Greenough, 
1989) was performed in a Plexiglas chamber with a tall narrow window in the center of 
the front wall. Animals were placed on scheduled feeding (13-17g rat chow/one time per 
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day) beginning two days before experiments began to motivate reaching behavior. All 
animals were given banana flavored food pellets (45 mg, Bioserve, Inc.) in their home 
cages for approximately two weeks before the start of reaching behavior to reduce 
neophobic responses to unknown food. Animals were shaped over several days on the 
tray reaching multiple pellets reaching task whereby a limb of preference (dominant limb 
for the task) was established (more than 15 reach attempts with same limb over a 20 
minute period). 
After a dominant limb was established, animals were trained on the single pellet 
retrieval task to a proficient level (> 40% success/reach attempt) with this forelimb. Pre-
operative training consisted of 15 min sessions in which, on each trial, rats could make up 
to 5 reach attempts for a banana pellet located in a shallow well (1 cm from the window). 
A trial ended when greater than 5 reach attempts (extension of the forepaw through the 
window) were made or the pellet was knocked from its well (failures), the pellet was 
dropped inside the chamber before consumption (drop), or when the pellet was 
successfully retrieved from its well and eaten. A short pause preceded each trial such that 
the animal was distracted from, or turned away from the center window (by tapping on 
the side of the chamber, or by dropping a pellet in the chamber) while a new pellet was 
placed in the well to begin the nest trial.  
Sunflower seed opening test. Rats are inherently adept at opening shelled seeds to 
obtain food, and sunflower seed opening is an effective measure of bilateral object 
manipulation (Whishaw, et al., 1998) as well as a good detector of motor impairments 
after stroke (Gonzalez & Kolb, 2003). Each rat was placed in a rectangular Plexiglas 
chamber and given five sunflower seeds. Rats start by manipulating the seed into a 
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preferred position before shelling. They then chew away a corner of the seed in order to 
facilitate splitting it longitudinally and finally the seed is split open into two or more 
pieces. In this task the total amount of time it took the animal to manipulate, open and 
consume all five seeds as well as the number of pieces of shell the animal had to break to 
retrieve the seed was measured.  
Vermicelli handling trials. A test consisted of 4 trials with 7 cm long pasta pieces 
given one at a time per each trial. The experimental set up was similar to the one 
described in (Allred, et al., 2008). Data were collected with the rat facing the 
experimenter such that the digits and joints of the metacarpals and phalanges of both 
forepaws could be seen. The rats exhibited typical holding patterns, as previously 
described by (Whishaw & Coles, 1996). Time to eat was recorded, beginning when the 
pasta piece was grasped and placed in the mouth and ending when the piece was released 
by the paws and disappeared into the mouth. Total number of paw adjustments made 
while consuming the pasta for each trial were also recorded.  
Forelimb use asymmetry. The Schallert cylinder test was used to examine 
asymmetries in forelimb use for postural support during explorative activity by placing 
each rat in a transparent cylinder 20cm in diameter and 30 cm high for 3 min (Schallert, 
et al., 2000). This test encourages upright support against the cylinder wall, which 
sensitively reveals forelimb asymmetries. Rats were videotaped in the cylinder and then, 
during slow-motion video play back, instances of the sole use of the ipsilateral (to the 
lesion) or contralateral forelimb or the simultaneous bilateral use of both forelimbs for 
upright support was recorded.  
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Behavior was quantified by determining the occasions when the unimpaired 
(ipsilateral) forelimb was used as a percentage of total number of limb use observations 
on the wall; the occasions when the impaired forelimb (contralateral to the blood 
injection site) was used as a percentage of total number of limb use observations on the 
wall; and the occasions when both forelimbs were used simultaneously (or nearly 
simultaneously during lateral side-stepping movements) as a percentage of total number 
of limb use observations on the wall . The ipsilateral asymmetry score was computed 
using the formula: % (ipsilateral forelimb support+1/2 bilateral forelimb 
support)/(ipsilateral+contralateral+bilateral forelimb support). Forelimb placement during 
rearing, wall exploration and landings were recorded to determine forelimb asymmetry. 
Oral Motor Testing 
Plethysmography. Respiratory behavior in unanesthesized rats was characterized 
by utilizing a plethysmography chamber. In Plethysmography rat’s functional lung 
capacity is measured by exposing them to normal air to obtain a baseline followed by 
intermittent periods of hypercapnia. Ventilatory parameters measured in this task are 
breathing frequency, tidal volume and minute ventilation. This chamber utilizes physical 
principles established by the Boyle-Mariotte law to determine volume and pressure 
changes for data collection.  Theoretical basis for this method may be presented by 
considering the conditions influencing air temperature and vapor pressure within a closed 
chamber, the temperature, and vapor pressure of the air contained within the lungs of an 
animal within the chamber. Drorbaugh and Fenn equation is used to calculate respiratory 
volumes including minute ventilation (ml/min/100 g) and tidal volume (ml/100 g). 
Overall breathing frequency (breaths/min), the duration of inspiration and expiration, and 
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peak airflow rates were calculated from the airflow traces. During the experiments, 
pressurized gas mixtures flowed through the chamber at a rate of 2 L/min to enable 
control of inspired gases (DRORBAUGH & FENN, 1955). Baseline recordings lasted 1–
1.5 h and were made while the chamber was flushed with 21% O2 (balance N2) (i.e. 
eucapnic normoxia). Rats were then exposed to a 10 min period of hypercapnic gas (7% 
CO2, 21% O2, balance N2). Rectal temperature was measured immediately before rats 
were placed in the chamber, and again immediately after the hypercapnic exposure.  
 
 
Figure 5.2A Plethysmography apparatus; 5.1B Examples of 
respiratory behavior recorded with barometric plethysmography in 
awake rats 
Licking Task. Lick apparatus is used in rats to quantify behavior expressed by the 
tongue by measuring lick frequency (breaths per second), force (g), and rhythm (cycles 
per second). This enclosure contains a lick disk (18mm in diameter) attached to the shaft 
of a force transducer with a computer controlled peristaltic pump that delivers water to 
the center of the lick disk through a 0.5mm diameter hole. The force transducer is capable 
of resolving force measurements to 0.2g equivalent weights. Through a Labmaster 
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interface (Scientific Solutions, Mentor, OH) a computer program records session force-
time data at a rate of 100 samples per second allowing for force-time waveforms of each 
individual lick. During training, the force requirement for a water bolus reward is set at 
2g and continuous licking behavior is reinforced by delivery of 0.06ml of water to the 
lick disk surface after every 12th lick (fixed-ratio of FR12 schedule) (Figure 5.3).  
 
 
   Figure 5.3 Lick Apparatus 
 
 
 
Ischemic Insult 
  Unilateral ischemia was induced by slowly injecting endothelin-1 (80 pmol) via 
Hamilton syringe in the proximity of the middle cerebral artery contralateral to the 
animal’s preferred reaching paw (Windle et al., 2006), (Adkins, Voorhies, & Jones, 
2004). 
Mapping Procedure 
  Intracortical microstimulation (ICMS) techniques were used to generate detailed 
ipsilesional maps of forelimb regions of the motor cortex. Prior to surgery animals were 
anesthetized with ke7,8 DHF tamine hydrochloride (70 mg/kg intraperitoneally [i.p.]) and 
xylazine (5 mg/kg i.p.). Animals received supplemental doses of ketamine (20 mg/kg i.p.) 
and xylazine (0.02 mg/kg i.p.]) as needed. A digital image of the cortical surface was 
taken and a 500-µm grid was superimposed onto the image. A glass microelectrode 
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(controlled by a hydraulic microdrive) was used to make systematic penetrations across 
the cortex using the cortical surface image and grid as a guide. At each penetration site, 
the electrode was lowered to approximately 1550 µm (corresponding to cortical layer V). 
Animals were maintained in a prone position with the limb consistently supported. Sites 
where no movement was detected at ≤60 µA were recorded as unresponsive. Forelimb 
movements were classified as either distal (wrist/digit) or proximal (elbow/ shoulder) and 
representational maps were generated from the pattern of electrode penetrations (Fig. 5a). 
An image analysis program (CANVAS v. 3.5) was used to calculate the areal extent of 
the CFA. Briefly, each map was imported into CANVAS and calibrated to magnification. 
Individual areas were traced using the marquis tool to produce a measure of area (mm2). 
Histology and lesion verification 
Rats were given an overdose of sodium pentobarbital and intra-cardially perfused 
with 0.9% saline followed by 4% paraformaldehyde solution immediately after mapping. 
The brains were removed and post fixed in 4% paraformaldehyde solution for 24-48 hrs 
and then finally placed in a 30% sucrose-formalin solution for 3 days before being cut 
frozen on a microtome. The brains were sectioned coronally at a thickness of 40µm. 
Sections were collected in a chilled 0.1M phosphate buffer solution and one series of 
every seventh section from the cortex and the sub-cortex was mounted on subbed slides 
and stained with cresyl violet to demonstrate Nissl substance (Morecraft, et al., 1992). 
Myelin staining was also carried out in the same sections. The mounted sections 
represented every 240-µm intervals in an individual series of tissue sections on the slides. 
Infarct size was determined by measuring areas of noninfarcted tissue in both the 
damaged and undamaged hemispheres. Lesion volumes were indirectly estimated based 
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on interhemispheric volume differences by tracing whole cerebral hemispheres in 
sections 440 µm apart using Image J software. 
Statistical analyses 
One-way ANOVA and t-test statistical analysis was performed using SPSS 
software, with results displaying a p value less than or equal to 0.05 were considered 
significant. All descriptive statistics are reported as means ± S.E.M. unless otherwise 
indicated. 
5.3 Results 
5.3.1 Unilateral cortical ischemia causes forelimb motor deficits 
Single Pellet Reaching. In the skilled reaching task, both groups had about the 
same amount of successful retrieval percentage in pre-injury trials (MCAO = 44.1%, 
Control = 42.66%), but the MCAO group showed a significant decrease in successful 
pellet retrieval percentage during post-injury trials.  Control animals displayed an average 
of 44.11% ± 5.7% during post-lesion tests, whereas MCAO animals averaged only a 
14.6± 7.98% successful retrieval rate.  These results were highly significant (p < 0.02) 
and demonstrated a marked difference between the two groups (Figure 5.4).  
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Figure 5.4 Single Pellet Reaching. Skilled reaching data showing the 
percent decrease in successful reaching rate between pre-injury and post-
injury testing.  A statistically significant difference was observed between 
the MCAO and control groups during post-injury testing (p ≤ 0.03). 
 
Sunflower Seed Opening Test. This test revealed deficits in fine motor skills in 
MCAO rats. There was a significant difference between the two test groups during post-
injury testing.  During pre-injury tests, the two groups showed no significant differences 
in average time taken to complete the task (control = 52.6 ± 2.5 sec, MCAO = 58.2 ± 
5.7sec).  However, during post-injury trials MCAO animals spent an average of 83.9 
seconds to eat the five sunflower seeds, while the control group spent only 55.5 ± 3.2 
* * 
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seconds completing the task.  The differences between the MCAO and control animals 
during post-injury testing were highly significant (p = 0.0004).  Also, it took MCAO rats 
much longer to complete this task between pre and post-lesion trials.  This group 
displayed a 30.6% increase in the average completion time between pre and post-lesion 
testing (Figure 5.5). There were no significant differences in the number of pieces the 
shell was broken into pre (12 ± 1.2 pcs) and post (11.59 ± 1.1 pcs) injury.  
 
Figure 5.5 Sunflower seed opening test. Sunflower seed data showing 
MCAO rats taking more time to consume seeds. Statistically significant 
difference (p = 0.0004) in task completion time was observed between the 
two groups during post-lesion testing. 
 
Vermicelli Handling Test. In the Vermicelli pasta handling task forepaw 
dysfunction was measured. MCAO rats demonstrated a marked increase in the number of 
adjustments made with the non-affected pas between pre-lesion and post-lesion trials.  
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MCAO rats displayed a 22.3% increase in the number of non-affected paw adjustments 
made during the past handling task between pre-lesion and post-lesion trials (Figure 5.6).  
MCAO animals had an average number of 14.8 ± 2.33 adjustments/trial with the non-
affected limb in post-lesion trials whereas the control animals averaged only 6.42 ± 0.74 
adjustments/trial during post-lesion testing.  There was a significant difference between 
the two test groups (p ≤ 0.03).  No significant difference was found between pre and post-
lesion trials in the affected paws of either group (Figure 5.6).  
           
Figure 5.6 Vermicelli handling task: No. of adjustments with Non-
affected paw/trial. MCAO rats made considerably more adjustments  
with their non-impaired paw per trial. A statically significant difference (p 
≤ 0.03) was observed between control and MCAO rats during post-lesion 
testing. 
 
Cylinder Paw Placement Test. In the cylinder paw placement task, no statistically 
significant differences were revealed in forelimb asymmetries between the MCAO group 
and the control group during the pre-lesion and post-lesion testing. During pre-injury 
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testing, the average asymmetry ratio between the two groups was almost identical 
(control = 49%, MCAO = 50%), as well as the average wall contacts made by the 
dominant paw (control =35%, MCAO = 36%) and average non-dominant paw (control = 
38%, and 37%). During post-injury testing, no statistically significant differences were 
seen between testing groups during pre-injury and post-injury cylinder task testing. 
During post injury testing, the average asymmetry ratio (control = 55 ± 7.6 %, MCAO = 
42 ± 10.24 %), average dominant paw use (control = 41%, MCAO = 33%), and average 
non-dominant paw use (control = 31%, MCAO = 48%) was almost identical.  
5.3.2 Unilateral MCAO did not induce significant deficits in breathing or licking 
behavior  
Plethysmography. No significant irregularities were observed in breathing 
patterns using the plethysmography apparatus. During post-injury testing, MCAO 
animals averaged 163  ± 44 breaths per minute during the challenge portion of this test 
while control animals averaged 173 ± 70 breaths per minute.  These numbers varied from 
their base line measures of challenge trials where MCAO and control animals averaged 
about the same breathing frequency (MCAO = 143 ± 53 bpm, control = 132 ± 61 bpm) 
(Figure 5.7). 
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Figure 5.7 Breathing frequency measured viaPlethysmography. Bar 
graphs representing the ventilator parameter frequency (breaths per min) 
in MCAO and control animals.  No statistical significant differences were 
observed in any pre-lesion or post-lesion testing. 
Lick Task. During the lick force testing no statistically significant 
difference was found between groups in pre-lesion or post-lesion testing. Average 
peak force (g) during pre-lesion testing was 45.9 ± 5.1g for the control group, and 
42 ± 6.9g for the MCAO animals.  Average peak force during post-lesion testing 
was 40 ± 3.71g for the control group, and 37 ± 4.9g for the MCAO group (Figure 
5.8).   
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Figure 5.8 Lick Force (g). No statistically 
significant differences were observed 
between the groups during pre or post-
lesion testing. 
 
No statistically significant differences were observed between the MCAO and 
control groups during pre-injury or post-injury licking rhythm values.  The average 
licking rhythm for the control group during pre-lesion trials was 7 ± 0.3 Hz, and the 
average rhythm for MCAO animals was 6 ± 0.4Hz.  The average licking rhythm for the 
control groups during post-lesion trials was 6.5 ± 0.21Hz for the control group, and 5.8 ± 
0.29Hz for the MCAO group (Figure 5.9). 
          
   
 
 
 
 
Figure 5.9 Lick Rhythm (Hz) 
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5.3.3 MCAO animals had significantly smaller forelimb motor maps compared to 
controls 
Consistent with the behavioral findings, overall forelimb motor maps of MCAO 
animals were significantly smaller in area than those of control rats (1.7 ± 0.69mm2 and 
6.3 ± 0.8mm2 respectively) (p=0.007). The most pronounced differences between the two 
groups were seen in distal rostral and caudal forelimb representations. For total caudal 
forelimb representations, control animals had an average motor map area of 5.34 ± 0.76 
mm², while MCAO rats had an average map size of 1.4 ± 0.65 mm² (p=0.01). Most 
notable differences were seen between MCAO and control groups for distal caudal 
forelimb representations.  Control animals had an average distal caudal forelimb area of 
4.22 ± 0.4 mm2 while MCAO animals had significantly smaller map size of 1.01 ± 0.43 
mm2 (Figure 5.10).  
 
Figure 5.10 Caudal forelimb area. Bar graphs comparing average caudal 
forelimb motor map area.  Control animals had a larger motor map size in 
proximal, distal, and total caudal forelimb area representations, with 
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statistically significant differences between the two groups observed in the 
total and distal caudal forelimb area. 
In rostral forelimb representations, total rostral forelimb area in controls was 
significantly larger than MCAO rats (0.98 ± 0.15 mm2) only the distal forelimb 
representations displayed significant difference between the control and MCAO groups 
(Figure 5.11).  Control rats had an average distal rostral forelimb map size of 0.98 ± 0.15 
mm2 while MCAO rats had an average size of 0.32 ± 0.13 mm². 
 
 
Figure 5.11 Rostral Forelimb Area. Control animals had larger motor 
maps in proximal, distal, and total rostral forelimb area representations, 
with a statistically significant difference between the two groups in the 
distal forelimb area. There was no significant difference between proximal 
caudal forelimb areas in the two groups.  
 
5.3.4 MCAO had no impact on oral motor representation
No significant difference in oral motor (jaw and tongue) cortical representations 
was found between MCAO and contro
Figure 5.12 Oral motor map area of tongue and jaw representation. 
No statistically significant difference was observed 
and control groups.  
     
Figure 5.13 MCAO representative motor maps
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Figure 5.14 Control rat 
representative motor maps 
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5.4 Discussion 
Animal models of cortical ischemia have predominantly focused on upper extremity 
impairments after stroke. However, there is some evidence that the same manipulation 
can induce deficits in licking (Whishaw et al., 1987; Skitek et al., 1999), chewing 
(Whishaw et al., 1997) and breathing parameters. The aim of this study was to investigate 
whether middle cerebral artery occlusion can induce changes in tongue dynamics with 
noted reductions in lick force, frequency and rhythm (Ciucci & Connor, 2009; Fowler & 
Mortell, 1992; Fowler & Wang, 1998). Unfortunately, there has been little investigation 
into the differential neural mechanisms underlying cranial motor versus upper extremity 
impairments in these models. To address this issue a behavioral paradigm in an animal 
model was established that directly compared upper extremity and cranial motor 
impairments and measured concomitant changes in corticospinal and corticobulbar 
circuitry.  
Results from this study show that corticospinal system, which is predominantly 
involved in upper extremity movements and more fractionated fine digit manipulations is 
affected by middle cerebral artery occlusion, whereas cranial motor function involved in 
mouth, tongue, jaw and to some extent diaphragm movements remained unaffected by 
MCAO. Post injury behavior testing began a month after stroke induction in order to 
assess enduring impairments in chronic stage and minimizing the impact of spontaneous 
recovery influencing the behavioral outcome. Rats with MCAO displayed significant 
impairments in the Vermicelli pasta handling task, single pellet reaching, and sunflower 
seed opening task compared to control animals.  However, no significant differences 
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were seen between MCAO rats and controls in the cylinder task, measuring forelimb 
asymmetries, and tests assessing tongue or respiratory behavior.  
In vermicelli pasta handling task more adjustments were made with the non-
affected limb by the MCAO group, and in skilled reaching task MCAO animals showed a 
significant decline in successful retrieval rate.  In the sunflower seed opening task, 
MCAO rats took much longer compared to the control group to consume all five 
sunflower seeds. This correlates with the differences seen in motor map areas in the 
MCAO group. In caudal and rostral forelimb motor map representations, the distal 
forelimb area differed significantly between the two groups.  In both instances, MCAO 
rats had a much smaller motor map size for distal forelimb representations. The decreased 
representation of distal forelimb area in both caudal and rostral forelimb area in the 
MCAO group explains the sunflower seed, skilled reaching task, and Vermicelli handling 
task results. Distal forelimb area representations correspond to motor movement in the 
upper extremity, involving wrist and digits.  The noticeable decrease in distal forelimb 
area map size implies that a considerable region of the sensorimotor cortex sends 
descending axonal projections through the corticospinal tract controlling paw and fine 
digit movements. The decrease in area explains why the tasks most oriented to test distal 
upper extremity movement displayed the most significant differences between control 
and MCAO groups. 
The corticospinal system, responsible for upper extremity movement, is largely 
under unilateral control, with 90% of axonal fibers terminating on the contralateral side 
of the spinal cord (Lemon & Griffiths, 2005).  A unilateral injury due to middle cerebral 
artery occlusion results in profound motor impairments in the limb contralateral to the 
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site of the lesion, as was evident from these results. For this purpose, single pellet 
reaching task is considerably sensitive in detecting deficits occurring from such injuries. 
MCAO rats were less successful in retrieving pellets after injury compared to controls.  
In the sunflower seed task, MCAO rats took longer for task completion and were unable 
to carry out fine digit manipulation in the same manner as in pre-lesion testing. The 
Vermicelli pasta handling task data reveals compensatory behavior adopted by the 
animals after stroke. Injured rats made more adjustments per trial with their unaffected 
paw in order to compensate for the lack of fine motor ability in the affected paw.  
The relatively unaffected cranial motor function and no significant size 
differences observed for oral motor maps between control and MCAO groups may be 
explained by the fact that the infarct produced in the stroke model used appeared to spare 
the oral motor areas of the motor map. Furthermore, the corticobulbar tract innervates 
cranial muscles bilaterally.  Since both brain hemispheres can control cranial motor 
function, unilateral injury is associated with less prominent functional deficits due to 
compensation by the intact hemisphere. In addition, breathing is primarily controlled by 
phrenic motoneuron pools located in the mid cervical spinal cord between C3-C6, 
innervating muscles of the diaphragm and phrenic motoneuron pools receive projections 
from bulbospinal fibers (Fuller, 2003). However, voluntary control of breathing is driven 
from the cerebral cortex (i.e. speaking, breath holding) (Davenport & Vovk, 2009; 
Redline et al., 2007). Typically after a spinal cord injury altered respiratory patterns are 
generally characterized by increased breathing frequency (Fuller, Johnson, Olson, & 
Mitchell, 2003). Interestingly, MCAO rats in this study showed decreased frequency in 
breaths during challenge. Although this effect was not significant, it allowed for the 
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speculation that as a result of a unilateral cortical injury the system has reduced ability to 
engage cortical inputs due to loss of connections and the spinal cord is augmenting output 
during the respiratory challenge as a compensatory mechanism. 
Thus, motor cortex stroke affects corticospinal versus corticobulbar circuits 
resulting in different patterns of impairment in upper extremity versus cranial motor 
function. This may reflect differences in functional relationships between the primary 
motor cortex and the corticospinal versus corticobulbar system. The results may also 
reflect inherent differences in the functional anatomy of the two systems. Corticospinal 
projections have a greater laterality bias than corticobulbar projections, potentially 
affording a greater opportunity for contralesional compensation. For future studies it 
would be feasible to create a more robust injury model in order to observe the impact on 
bilaterally innervated cranial motor systems.  
 
 
 
 
 
 
 
 
 
 
 
109 
Chapter 6 
General Discussion 
6.1 Summary 
In these dissertation studies, principles of neural plasticity and their promotion by 
means of neurorehabilitation and adjuvant therapies have been investigated with the aim 
of enhancing functional outcome after stroke. The term ‘‘neural plasticity’’ might refer to 
transiently achieved functional changes in the context of learning and recovery, as well as 
structural changes manifesting as functional changes in synaptic efficacy, modifying 
protein synthesis and proteinase activity in nerve cells, creation of new anatomical 
connections or by altering synapses morphologically, and by specific apoptosis (Møller, 
2006). Pharmacological interventions can address several brain mechanisms that have 
been identified to be related to motor learning. Drugs have been studied in animal 
models, healthy volunteers, and stroke patients in single or multiple dosages, with and 
without additional therapeutic tasks. No single medication evaluated for its beneficial 
effect of modulating plasticity in the human M1 in stroke patients has reached class I 
evidence so far. 
The primary goal of these dissertations studies was to test the efficacy of TrkB 
agonists for enhancing cortical plasticity and augmenting motor recovery associated with 
cortical ischemia in rats. Characterization and measurement oral motor dysfunction in a 
rodent model after a unilateral middle cerebral artery occlusion was also studied.  
7,8 Dihydroxyflavone As An Adjuvant Therapy 
In Chapter 3 significant effects on positive behavioral outcome were seen within a 
few days of administration of a synthetic flavonoid derivative compound 7,8-DHF. The 
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improved behavior was more pronounced in tasks requiring fine digit manipulation, 
hence implying the involvement corticospinal tract. The integrity of cortcospinal tract is 
essential in successfully executing fractionated individualized movements. However, 
tasks employing gross motor movements failed to show any significant improvements as 
a result of the treatment. This finding is noteworthy because the targeted lesion is in the 
primary sensory motor cortex which projects axons directly to corticospinal tract, 
indicating that the compound is inducing factors that are keeping the tissue viable. It is 
difficult to say that these effects are a result of TrkB stimulation, because protein 
quantification did not reveal significant increase of the activated receptor. This may 
reflect either the failure of the compound to drive changes in TrkB signaling proteins or 
possibly the lack of sensitivity of the protein assays used. It is possible that the drug was 
driving other signaling pathways know to enhance neural plasticity outside of the TrkB 
receptor. For example, flavonoids have been shown to up regulate the NMDA receptor 
(Wang et al., 2011; Cao et al., 2009). 
7,8-DHF treated rats showed greater forelimb motor map areas than those of the 
vehicle injected animals and upon lesion verification it was seen that this was primarily 
due to the smaller lesion size in the DHF animals. It has long been established that 
ischemic strokes cause reorganization in M1 networks of the peri-infarct cortex and 
beyond. But interestingly the pattern of reorganization in these animals did not follow a 
linear correlation, as the expansion of motor maps was several times greater than the 
proportion of spared tissue in DHF receiving animals. This finding is contrary to what 
Nudo and colleagues have demonstrated in non-human primates where after large lesions 
destroying >50% of the M1 distal forelimb, the PMv distal forelimb invariably increased 
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in size, and the increased area positively correlated with the size of lesion (Nudo, 1996). 
It may be the case that 7,8-DHF is facilitating synaptic strengthening and promoting 
axonal sprouting in these brain regions.  
It is speculated that 7,8-DHF was not able to induce relaxation of the arteries 
because of the structural modification of 7,8-DHF for its reactivity. Naturally occurring 
flavonoids impart vasodilatory effects due to the presence of 4 carbonyl group (Duarte et 
al., 1993). In 7,8-DHF the 8-position hydroxyl group is essential for the compound to 
activate TrkB receptor. The neuroprotective effects of 7,8-DHF were evident by reduced 
infarct volume, but the underlying mechanism behind this finding remains somewhat 
elusive partly due to the fact that 5mg/kg dose administered was unable to enhance 
pTrkB expression in the sensory-motor cortex of healthy rats. Due to the absence of 
injury, it could be proposed that 7,8-DHF was ineffective in provoking TrkB receptors 
and the presence of endogenous BDNF was sufficient to carry out activation of its target 
receptors. In an event of an ischemic stroke the normal physiological range of BDNF and 
TrkB is disrupted, hence presenting a possibility for 7,8-DHF to take on the role of 
BDNF. 
LM22A-4 As An Adjuvant Therapy 
The experiments conducted to study the role of LM22A-4 (chapter 4) provide 
substantial support for how adjunct therapies following unilateral stroke like damage can 
influence behavioral recovery of the impaired forelimb and mediate peri-lesion neural 
plasticity. The use of animal model in these experiments expanded beyond the study of 
neuroprotection to studies directed at identifying the fundamental neural substrates that 
support rehabilitation-dependent functional improvement.  
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First, an effective dose was established by measuring the increase in protein levels 
of pTrkB using two varying dosages of LM22A-4. pTrkB levels in the ipsilesional motor 
cortex were increased by 27.7% in LM22A-4 administered (7d) post stroke. Further steps 
were taken to verify successful penetration of the compound into the brain by the help of 
mass spectrometry. Although the amount detected in the brain was low, due to 
intraperitoneal route of administration it was sufficient to induce increased in p-
TrkB/TrkB ratios after one week. Further, the drug was administered for a considerably 
longer period of time in experiment 2, which was designed to measure behavioral and 
neurophysiological correlates of LM22A-4. 
Evidence from clinical studies indicates that early start and high intensity of 
therapies are decisive for favorable long-term outcome. On the basis of 
pathophysiological data, the first 3 weeks after stroke are considered a particularly 
promising period. In animal models, active training leads to better functional recovery 
and sprouting, whereas inactivity results in additional loss of ability (Nudo 2006). Hence 
based on this evidence, a rigorous rehabilitation regime, in conjunction with 
pharmacological therapy, was enforced starting no later than three days post stroke to 
maximize functional recovery 
In Experiment 2 of Chapter 4, single pellet reaching task was utilized as the 
rehabilitation-training paradigm and also to analyze changes in the performance of the 
reaching movements. This method for qualitative reaching movement analysis is 
sensitive to compensatory forelimb movements that reveal enduring impairments or 
compensatory strategies in reaching and grasping motor action patterns after brain injury 
(e.g., Gharbawie et al. 2005a; Metz and Whishaw 2000; Whishaw et al. 1993). Several 
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other motor tasks measuring impairment profiles in upper extremity movement 
coordination, such as sunflower seed opening, vermicelli handling and cylinder test were 
also employed. After a unilateral stroke injury, animals appear to develop an exaggerated 
compensatory reliance on the intact forelimb. For example there is a tendency to increase 
reliance on intact limb is a measure of postural support movements, or rats using the aid 
of intact forelimb in successful retrieval of food pellets in skilled reaching.  Therefore, 
these tasks were instrumental in delineating recovery vs. compensatory patterns adopted 
by animals towards functional outcomes.  
The most encouraging finding from the study of LM22A-4 was the proficiency in 
reaching attained by severely impaired LM treated animals after three weeks of daily 
drug administration. Also, these rats demonstrated greater efficiency in bilateral 
manipulation skills while consuming sunflower seeds. This indicates that the drug 
preserves integrity of white matter tracts, which are essential in coordinating fine skilled 
movements. The neurophysiological manifestation of this behavior was seen in the 
expansion of secondary motor areas located distal to the site of injury. Based on previous 
studies in non-human primates, it is suggested that interruption of projections from the 
primary motor cortex (M1) leads to increased recruitment of secondary motor areas such 
as the dorsolateral premotor cortex and supplementary motor areas. Basic underlying 
mechanisms of these findings include both different functional use of existing networks 
and synapses, but also structural changes (Nudo, 2003, Kleim 2002). This effect of 
LM22A-4 was only seen in severely impaired animals which is indeed promising when 
translating these findings to the clinic.  
LM22A-4 administration provides compelling evidence of mediating synaptic 
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plasticity in peri-lesion cortex, which is usually disrupted as a result of ischemic injury. 
The ability for motor maps to reorganize is related to strengthening of synaptic 
connections, which is experience dependent (e.g., Kleim et al., 2002). The reorganization 
of peri-lesion cortex after stroke, including reorganization of motor maps, has been linked 
with functional recovery (e.g., Nudo, 2003). 
The finding that pTrkB expression is enhanced in peri-lesion cortex following 
LM22A-4 treatment indicates an increased capacity for receptor binding after stroke. 
Phosphorylation of TrkB through BDNF has been shown to both down regulate (in an 
acute stage) and up regulate (at a more chronic time point) various genes, including 
pCREB, which has been implicated in plasticity promoting mechanisms. Administering 
BDNF in the acute post-ischemic period reduces cell death and delayed treatment 
facilitates motor recovery in rats. These dissertation studies were able to provide proof-
of-principle that LM22A-4 is indeed mimicking BDNF by inducing similar cellular and 
behavioral outcomes in the effected systems.  
In the early course of ischemic stroke, pathophysiological mechanisms in the 
perilesional region are initiated, which include enhanced expression of plasticity-related 
proteins, neurotrophic factors (e.g., brain-derived neurotrophic factor, synapsin I), and 
certain neurotransmitters, but also expression of inhibitory factors occurs in the central 
nervous system. These modifications probably lead to morphological changes, e.g., 
synaptic plasticity and sprouting (Biernaskie, Chernenko, & Corbett, 2004). Off drug 
increase in performance indicates activation of TrkB receptor elevates levels of 
transcription factors that set up ongoing increment in synaptic function that may be 
sustained for weeks. 
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Animal Model Of Oral Motor Impairments After Stroke 
The final study of the dissertation examined at the impact of unilateral MCAO on 
limb motor and oral motor function provided important insights regarding the function of 
bilaterally innervated systems. Since dysphagia, dysarthria and malfunctioning in normal 
breathing control are common sequelae of stroke (Cameron D, 2000). Swallowing and 
food intake are important for quality of life and autonomy of patients and will for many 
patients be considered an important goal of rehabilitation. This study was an attempt to 
create an animal model of post stroke oral impairment. 
Rats with MCAO displayed a typical profile of upper extremity impairments, with 
enduring reduction in their single pellet reaching scores, exhibiting forelimb use 
asymmetries and forepaw dysfunction There were no prominent differences observed in 
the breathing patterns of MCAO and control rats, neither were there any tongue disorders 
detected trough the licking task. The relatively unaffected cranial motor function and no 
significant size differences observed for oral motor maps between control and MCAO 
groups may be explained by the fact that the infarcts produced in the stroke model used 
appeared to spare the oral motor areas of the motor map. Furthermore, the corticobulbar 
tract innervates cranial muscles bilaterally.  Since both brain hemispheres can control 
cranial motor function, unilateral injury is associated with less prominent functional 
deficits due to compensation by the intact hemisphere 
 
6.2 Translation To The Human Stroke Population  
The ultimate goal of these studies is to provide basic information that can guide 
116 
the development of effective clinical therapies.  Every attempt was made to develop an 
animal model that facilitates translation to human stroke patients. In these experiments 
upper extremity function was studied at several levels ranging from simple forelimb use 
to skilled reaching. ICMS techniques were used to measure changes in motor cortex 
organization similar to how TMS is used in human patients. While rats make good 
models of stroke-induced behavioral deficits that mimic, in some fashion, deficits seen 
after cortical strokes in humans (Whishaw et al., 1992; Sacrey et al., 2009) there are 
several key differences in these animal models that must be recognized when attempting 
to translate the results to the clinic.  
 First, these stroke animals are readily engaging key behavioral signals known to 
drive neural plasticity (intensity, timing and salience) that is not commonly observed in 
human patients. Enforcing food restriction prior to training makes the task more salient 
for the rats. Food pellets used as positive reinforcement makes them highly motivated and 
focused on the task at hand. Also, the animals make hundreds of attempts during each 
session in very short intervals of time therefore successfully incorporating repetition and 
intensity factors. Rats relearn or adapt combination of finger flexions and wrist 
extensions that were used normally prior to the stroke, hence reinforcing the timing 
element. Simultaneous delivery of LM22A-4 as an adjunct therapy to stimulate pro-
recovery molecular mechanisms facilitating the formation and reorganization of neural 
processes contributed a great deal towards attaining functional recovery. It may be 
possible that the beneficial effects of LM22A-4 may require such intense therapy and this 
must be recognized if the drug is to be moved forward into human clinical trials. 
A major concern following stroke is the loss of functionality and subsequent 
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learned disuse and overuse of the less-affected body side. While this may be 
advantageous especially during the acute post-stroke phase, in the long-term this 
experience is detrimental to impaired forelimb recovery and may mask the extent of 
actual impairment. This is especially problematic for human stroke patients but less so for 
rats. Rats are quadrupeds and therefore begin using their impaired forelimb immediately 
after stroke.  
A major limitation of these studies is the inability to directly apply this knowledge 
to human stroke populations, which are inherently diverse. Stroke incidence increases 
with age. These dissertation studies used young adult rats (approximately 5-6 months of 
age at stroke onset). In general, in clinical populations there are a variety of strokes, both 
subcortical and cortical, and recovery is dependent upon a multitude of factors, including 
size and location of the infarct, various comorbidities such as high blood pressure and 
obesity (Kleim, 2006). Animal studies are very well controlled, and the lesions produced 
in these dissertation studies were focal and highly conserved across animals and across 
studies. This control restricts data variability, making it feasible to ask these questions in 
an experimental model, but it also makes it more difficult to generalize to clinical 
populations. 
The single pellet reaching task was primarily used to assess impairment of the 
affected limb, but it is not a truly lateralized task because the non-reaching forelimb is 
used to help aid in reaching behaviors. It is possible that even greater impaired forelimb 
deficits would be revealed after training on a more unilateral task like the Montoya 
staircase task (Montoya, Campbell-Hope, Pemberton, & Dunnett, 1991). This task 
requires animals to reach for pellets placed on descending stairs in an apparatus 
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configured to allow reaches with only one forelimb (the side ipsilateral to placed pellets).  
Recently, some rehabilitation facilities have started incorporating these principles 
as part of the therapy session in the clinic and their preliminary results demonstrate 
promising outcomes. Catherine Lang’s group is one such example (Birkenmeier et al., 
2010). They worked with individual patients and let them determine specific tasks based 
on their interest and preference (salience). The researchers then established ways to 
progressively increase the difficulty level while providing feedback on performance. The 
intervention paradigm was rather intense including three one-hour sessions per week for 
six weeks during which the patients were challenged to perform 100 repetitions on each 
of the three different tasks they chose, thereby enforcing repetition and intensity. As a 
result, the patients showed a significant improvement in their active arm test scores. Thus 
it is possible to adapt standard rehabilitation interventions to more optimally drive the 
key behavioral signals and produce meaningful functional gains 
 
6.3 Over all conclusions: 
Stroke is the most common cause of long-term disability in adults. There are 
many parallels between postlesional neuroplasticity (relearning) and learning in the 
development of individuals as well as task learning of healthy persons. One key principle 
of neurorehabilitation is the repetitive creation of specific learning situations to promote 
mechanisms of neural plasticity in stroke recovery. Preliminary data from these studies 
suggests that therapies targeting neural signals will undoubtedly play a major role in 
neurorehabilitation in the near future. Exploiting behavioral signals with early initiation 
119 
of treatment, high intensity active therapies and use of potential enhancers of neural 
plasticity e.g., pharmacological augmentation, have proven to be quite promising.  
 
6.4 Future directions:  
There remain many unanswered questions and possibilities for future studies. It 
would be feasible to test the efficacy of the novel TrkB agonists used in these dissertation 
studies in non-human primates conjunction with intense physical therapy (for example, 
constraint induced movement therapy). However in order to effectively translate it to 
clinic, these findings need to be replicated, large controlled trials need to be conducted, 
and patient selection criteria reapproved before pharmacological augmentation can be 
generally recommended.  
The two novel TrkB agonists investigated in the studies have shown to mimic 
BDNF’s role in the brain. BDNF mechanisms have been implicated in learning and 
memory and higher cognitive functioning paradigms, hence these compounds have great 
potential to enhance cognitive abilities. It would be encouraging to design experiments 
with the goal to study ameliorative effects of these compounds on stroke dementia and 
higher cognitive disorders. Regardless of what studies may be done in the future, this 
dissertation demonstrates that adjuvant pharmacological therapies that drive key neural 
signals orchestrating neural plasticity can significantly enhance motor recovery and 
cortical plasticity after stroke. 
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